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Abstract 
Introduction: The management of type one diabetes mellitus (T1D) in children and adolescents 
involves a complex and intensive daily self-management treatment regime (SMTR) in order 
to achieve optimal glycaemic control and prevent associated long-term complications (World 
Health Organisation, 2006). Recent research has highlighted the importance of parenting 
style in promoting young people’s adherence to their diabetes SMTR. In particular, an 
‘authoritative’ parenting style is thought to correlate with better glycaemic control and 
adherence to a SMTR in adolescence, but as yet there are no systematic reviews to 
encapsulate the findings (Shorer et al., 2011). 
Objectives: This review aims to evaluate the current evidence base, which explores the 
impact of parenting style on young peoples’ glycaemic control and/or adherence to their 
diabetes SMTR and to establish whether a specific parenting style is optimal for improved 
adherence and glycaemic control. 
Method:  A systematic search strategy was employed to identify relevant articles, which 
report the effects of parenting style on young peoples’ glycaemic control and/or adherence to 
their diabetes SMTR. The articles were then screened using a priori inclusion criteria, which 
resulted in the inclusion of ten studies in this review.   
Results: In order to achieve optimal glycaemic control and improved adherence to the SMTR, 
the findings support the use of an authoritative parenting style when parenting adolescents 
with T1D. The evidence remains inconclusive in relation to children/pre-adolescents due to 
the paucity of research in this population. 
Conclusion:  Further research is required to develop effective parenting education programs 
which encourage the use of an authoritative parenting style, to help promote self-management 
adherence behaviours in young people with T1D. 
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Introduction 
Children and adolescents with type one diabetes mellitus (T1D) have a lifelong dependence 
on insulin in order to circumvent the severe and long-term consequences of hypoglycaemia 
(World Health Organisation, 2006). The management of this chronic illness is both complex 
and intensive; it involves a daily self-management treatment regime (SMTR) incorporating 
meal planning, repeated blood glucose testing, insulin injections and exercise (Seiffge-
Krenke, 2001). It can thus represent a substantial challenge for the individual and their 
family. Consequently, it is vital that the potential impact of the family context on a young 
person’s adherence to their diabetes SMTR is addressed and recognised.  
 
Research indicates that young people benefit from a cohesive family environment in which 
the parenting style is supportive and emotionally warm (Butler et al., 2007), whilst flexibly 
adaptive to the needs of the developing child (Beveridge & Berg, 2007). The original 
parenting research conducted by Baumrind (1966) depicted three different parenting styles 
which were intended to influence, teach and control a child’s behaviour: authoritarian 
(telling their children exactly what to do), permissive (allowing their children to do whatever 
they wish) or authoritative (providing rules and guidance without being overbearing). This 
model was later extended to include negligent parents (disregarding their children and 
focusing on other interests). The literature suggests that authoritative parenting styles are 
most often associated with the highest achievement levels in young people and positive 
health outcomes, whereas the authoritarian parenting style is most often associated with 
poorer academic and health outcomes (Spera, 2005). This generic parenting model has been 
applied to chronic illnesses such as T1D and suggests that of all the family variables 
investigated to-date, parenting style is the optimum predictor of diabetes outcome (Davis et 
al., 2001). 
 
In the past ten years, research investigating parenting styles for young people with T1D has 
expanded to include both mothers and fathers parenting styles and has utilised a variety of 
measures. The most recent study by Shorer and colleagues (2011) examined the parental 
styles for Israeli adolescents who have T1D. The study reported that an authoritative 
parenting style of fathers was related to better glycaemic control and adherence to their 
SMTR in the adolescent, whereas a permissive parenting style of mothers was related to 
worse glycaemic control and lower adherence to their SMTR in adolescents. It appears that 
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parents who help their child or adolescent with their blood glucose levels but who have an 
authoritative parenting style (high levels of warmth, sensitivity and expectation for 
adherence) are likely to facilitate increased blood glucose monitoring and/or to support them 
to make sensible food choices. In contrast, parents who are involved in their child or 
adolescent’s blood glucose monitoring within the context of an authoritarian parenting style 
(high levels of expectation for adherence and low levels of sensitivity and warmth) will likely 
inhibit their child’s adherence to blood glucose monitoring or healthy food choices 
(Anderson, 2011). 
 
 
Rationale and Objectives 
There have been numerous studies published recently which have investigated the effect of 
parenting style on young peoples’ adherence to their SMTR and glycaemic control; yet a 
systematic review has not been conducted to encapsulate the findings. Hence, this review 
aims to determine whether parenting style has an effect on young peoples’ glycaemic control 
and/or adherence to their diabetes SMTR and to establish whether a specific parenting style is 
optimal for improved adherence and glycaemic control levels. 
 
 
Method 
 
Search Strategy  
The following electronic databases were searched: MEDLINE, EMBASE, PsychInfo and 
CINAHL. Additional searches utilising the Web of Science and Google Scholar were also 
included, alongside a review of the reference section of the final ten articles. The databases 
were limited to years 2001-2011, English language and humans. The following search terms 
and boolean operators were used: 
 
[type one diabetes or type one diabetes mellitus or diabetes] 
 
AND 
 
[adherence or non-adherence or compliance or non-compliance or management] 
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AND 
 
[parent or parenting] 
 
AND 
 
[child or children or adolescent or paediatric or youth or young people or teen or teenager or 
teenagers] 
 
The search generated a total of 71 studies; screening titles led to the removal of duplicated 
and irrelevant studies, leaving 24 potentially relevant papers (see Figure 1). The following 
inclusion/exclusion criteria were applied to the abstracts from these studies to screen for 
suitability. 
 
Inclusion Criteria; 
 Published in a peer reviewed journal 
 Published in English language 
 Participants must include children or adolescents with T1D (up to age 18)  
 Parenting style must be identified, measured and reported. 
 Young peoples’ glycaemic control and/or adherence to SMTR (e.g. diet, exercise) 
must be measured and reported. 
 
Exclusion Criteria; 
 Reviews, dissertations and single case studies. 
 Qualitative methods. 
 
Studies which failed to meet these requirements were excluded from the study, resulting in 
six studies being identified as suitable for inclusion in this review. To ensure the validity of 
the results, the reference lists from these final six studies were screened, generating a further 
four studies. Finally, the reference lists of these four studies were also hand-searched but did 
not yield any further studies which met the above inclusion and exclusion criteria. Ten 
articles were reviewed in total. 
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Figure 1: Flow diagram of review selection process 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
The following databases were 
searched: 
 MEDLINE 
 PsycInfo  
 EMBASE 
 CINAHL  
 Google Scholar  
 Web of Science 
 
Articles Identified n =71 
n = 24 
Full text obtained and detailed 
examination  
Reason for exclusion: 
 
 Duplicates 
 
Excluded n = 24 
Final Articles included in this 
review: 
n = 10 
n = 6 
References examined, Further 4 
articles identified 
n = 47 
Abstracts screened 
Reason for exclusion: 
 No outcome data relevant 
to the question of the 
review 
 Focus on family 
behaviours 
Excluded n = 18 
 
 
Excluded n = 18 
Reason for exclusion: 
 
 Irrelevant articles (e.g. 
reviews, presentations)  
 Utilised qualitative methods  
 Did not examine parenting 
style  
 Did not examine adherence 
to SMTR and/or glycaemic 
control 
 
Excluded n = 23 
 
 
Excluded n = 24 
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Procedure 
The final ten studies were evaluated using a quality assessment tool which was developed by 
the researcher following consultation of the Scottish Intercollegiate Guideline Network 
methodology (2011), the CONSORT Statement on the review of Randomized Trials of Non-
pharmacological Treatments (Schulz et al., 2010) and Downs and Black’s (1998) checklist.  
The quality assessment tool is detailed in Appendix 1.2. Each study was awarded points in 
accordance with the following areas: internal validity, introduction, method, assessment, 
confounding variables, statistical analysis and discussion. A maximum of 36 points could be 
awarded, with (A) representing a percentage score of 80% or above (good quality), (B) 
representing a percentage score of 55-79% (acceptable quality) and (C) representing a 
percentage score of 0-54% achieving a poor quality score. 
 
Each paper was rated independently by an experienced researcher in order to ensure the 
validity and reliability of the quality assessment tool and discussion took place in order to 
reach agreement on all items. 
 
Results 
 
Quality rating of studies 
An overview of the final ten studies included in the review is presented in Table 1. Table 1 
presents the following information: primary aims, participants, adherence/glycaemic control 
measure, parenting measures, data analyses and main findings. For the sake of brevity, the 
studies will be referred to by the first author’s surname from here on. 
Overall, five studies (50%) were rated as ‘good’ quality (Armstrong, Greene, Duke, Lewin, 
Davis) and five studies (50%) were rated as ‘acceptable quality’ (Shorer, Jaser, Sherifali, 
Faulkner, Butler). See Appendix 1.3 for details. 
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Table 1: Overview of reviewed studies
1
 
 
 
Study (Country 
and Quality 
Rating %) 
Primary Aim Participants 
Adherence/Glycaemic 
Control Measures 
Parenting Measures Data Analysis Main Findings 
Shorer et al., 
2011 
 
Israel 
 
55.6% 
To determine the parental 
factors that predict 
adherence and glycaemic 
control 
100 adolescents 
(aged 11-18years) 
with T1D and their 
parents 
 
Diagnosed at least 1 
year previously 
Adherence to 
Diabetes Treatment 
Regimen 
Questionnaire 
 
HbA1c 
 
Parental Authority 
Questionnaire 
 
 
Correlation 
and multiple 
regression 
Authoritative parenting style was associated 
with better adherence and glycaemic control 
in adolescents, whereas authoritarian and 
permissive parenting styles predicted poorer 
outcomes. 
Armstrong et 
al., 2011 
 
USA 
 
86.1% 
To elucidate the 
relationship of critical 
parenting behaviours, 
child depressive 
symptoms, child self-
efficacy for diabetes care 
and self-care behaviour in 
preadolescents 
84 pre-adolescents 
(aged 9-11 years) 
with T1D and their 
parents 
 
 
55% on insulin 
injections 
43% on insulin pump 
or MDI 
 
 
Self-Care Inventory 
(Child and Parent 
Version) 
 
A1c 
Diabetes Family 
Behaviour 
Checklist 
 
 
Correlation 
and 
hierarchical 
linear 
regression 
Critical parenting behaviours were 
significantly associated with depressive 
symptoms and self-efficacy. 
 
No relation between self-care behaviours and 
glycaemic control. 
 
No significant correlation between critical 
parenting behaviour and self-care behaviour. 
Greene et al., 
2010 
 
USA 
 
88.8% 
To explore the 
relationship among 
glycaemic control, self-
care behaviours and 
parenting in adolescents 
with T1Ds. 
29 adolescents (aged 
10-18 years) with 
T1D and their 
parents. 
 
Diagnosed with 
diabetes for at least 
two years 
 
 
 
The Diabetes Self-
Care instrument 
 
A1c 
62-item Parenting 
Practices report 
 
 
Correlation 
and 
regression 
analyses 
Self-care behaviours did not significantly 
correlate with A1C values 
 
Authoritative parenting was positively 
correlated with glycaemic control and overall 
scores on self-care. Of this, authoritative 
mothering was the strongest predictor of 
glycaemic control. 
                                                 
1
 The references for adherence and parenting measures can be found in the relevant sections in the review on pages 17 – 18. 
 
13 | P a g e  
 
Jaser and 
Grey, 2010 
 
USA 
 
75% 
To provide effect sizes of 
the relationships between 
specific observed 
parenting variables with 
maternal anxiety and 
depression, and 
adolescents’ depressive 
symptoms, quality of life 
and glycaemic control. 
30 adolescents (aged 
10-16 years) with 
T1D and their 
mothers. 
 
Diagnosed with 
diabetes for at least 6 
months 
The Pediatric Quality 
of Life Inventory 
 
 
HbA1c 
The Iowa Family 
Interaction Rating 
Scale 
Correlation Higher levels of observed maternal hostility 
was related to poorer glycaemic control. 
Whereas, higher levels of child-centered 
parenting were related to better glycaemic 
control. 
 
Intrusive parenting was related to 
adolescents’ quality of life and depressive 
symptoms. 
Sherifali et al., 
2009 
 
Canada 
 
77.8% 
 
Exploratory approach 
examining possible 
relationships among 
diabetes control, quality 
of life and parenting 
styles. 
216 children and 
adolescents (aged 5-
12 years) and their 
parents 
 
Diagnosed with 
diabetes for at least 1 
year 
 
 
 
The Pediatric Quality 
of Life Inventory 
 
A1c 
 
 
The Parenting 
Dimension 
Inventory 
Correlation 
Most parents exhibited an authoritative 
parenting style for nurture, consistency, and 
control, but also exhibited a permissive 
parenting style with respect to maturity 
demands. 
 
Parenting style did not correlate with 
glycaemic control, or the child’s report of 
quality of life. 
 
Duke et al., 
2008 
 
USA 
 
 
83.3% 
1. To examine if diabetes-
specific measures of 
family functioning 
accounted for significant 
variance in HbA1c. 
 
2. To examine if the 
relationship between 
critical parenting and 
HbA1c was mediated by 
adherence. 
120 children and 
adolescents (aged 
8.25 – 18.75 years) 
and their caregivers 
 
Diagnosed with 
diabetes for at least 6 
months 
Diabetes Self-
Management Profile 
 
HbA1c 
 
 
Diabetes Family 
Behaviour Scale 
 
Diabetes Family 
Behaviour 
Checklist 
 
Correlation 
and 
hierarchical 
linear 
regression 
Young people reported that critical parenting 
significantly predicted HbA1c. 
 
Critical parenting was associated 
significantly with HbA1c and adherence 
 
Faulkner and 
Chang, 2007 
 
USA 
 
1. Do age, sex, race, 
parental education, family 
behaviour and duration of 
diabetes predict 
participation in self-care 
99 children and 
adolescents (aged 10-
18 years) with T1D. 
 
 
 
 
Self-Care 
Questionnaire 
 
Diabetes Family 
Behaviour Scale 
Independent 
t-tests, 
correlations, 
and stepwise 
regression 
Families that exhibited more positive 
emotional support, and communication had 
children or adolescents who had higher levels 
of self-care participation, experienced a 
lower impact of diabetes, had fewer worries 
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77.8% 
activities? 
 
2.  Do age, sex, race, 
parental education, family 
behaviour and duration of 
diabetes predict QoL or 
glycaemic control of 
glucose levels? 
 
Diagnosed with 
diabetes for at least 1 
year. 
 
All insulin treatments 
included 
The Diabetes Quality 
of Life Instrument 
 
HbA1c 
about diabetes and experienced greater life 
satisfaction. 
 
The fathers’ educational levels was the only 
significant predictor of HbA1c. 
 
 
Butler et al., 
2007 
 
USA 
 
75% 
To examine aspects of 
adolescent well-being and 
the associations with 
adolescent and mothers’ 
perceptions of three 
dimensions of maternal 
parenting style. 
78 adolescents (aged 
11.58 - 17.42) with 
T1D and their 
mothers. 
 
Diagnosed with 
diabetes for at least 1 
year. 
Self-Care Inventory 
Child Report of 
Parent Behaviour 
Inventory 
 
Parent Report of 
Parent Behaviour 
Inventory 
 
 
Correlation 
and 
regression 
analyses 
Adolescent reports of psychological control 
or firm control were unrelated to adherence. 
 
Adolescent reports of acceptance were 
unrelated to adherence. 
 
 
Lewin et al., 
2006 
 
USA 
 
86.1% 
To test the relation 
between a combination of 
diabetes family 
functioning constructs and 
glycaemic control 
109 children and 
adolescents (aged 8 – 
18years) with T1D 
and their parents. 
 
Diagnosed with 
diabetes for at least 1 
year. 
 
Diabetes Self-
Management Profile 
 
HbA1c 
Diabetes Family 
Behaviour scale 
 
Diabetes Family 
Behaviour 
Checklist 
Correlation 
and 
hierarchical 
multiple 
linear 
regression 
Negative family functioning has a negative 
impact on children’s adherence behaviours 
and subsequent glycaemic control. Overall, 
children who reported more negative and 
critical relationships with their parents were 
in worse glycaemic control. 
Davis et al., 
2001 
 
USA 
 
80.6% 
Examine the relationship 
among parenting style, 
regimen adherence, and 
glycaemic control. 
55 children (aged 4-
10years) with T1D 
and their 
parent/guardian. 
 
About one fourth had 
been diagnosed with 
T1D in the past year. 
Self-Care Inventory 
 
GHb Assay 
The Parenting 
Dimension 
Inventory 
 
Correlation 
and 
hierarchical 
regression 
Parenting style was related to diabetes 
regimen adherence: more parental warmth 
was associated with better adherence. 
Whereas parental restrictiveness was 
associated with worse glycaemic control. 
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Demographic Information 
Overall, a combined total of 920 children and adolescents participated in the ten studies 
included in this review. Of these young people, 468 were females (50.9%) and 452 were 
males (49.1%), equating to an almost equal gender distribution. Five studies focused purely 
on adolescents (Shorer, Faulkner, Jaser, Butler, Greene), three studies on children 
(Armstrong, Davis, Sherifali) and two studies examined both children and adolescents (Duke, 
Lewin). The young peoples’ age ranged from 4 years to 18 years old. Ethnicity was reported 
by eight of the ten studies (Armstrong, Duke, Davis, Faulkner, Lewin, Jaser, Butler, Greene); 
on average, 77.3% of young people were Caucasian, resulting in the final 22.7% to be from 
either African-American, Hispanic or other ethnic background.  
 
Five of the ten studies reported the length of time the young people had been living with 
T1D, which averaged out as 5.6 years (Shorer, Faulkner, Lewin, Jaser, Greene). Three studies 
only reported a minimum duration; six months (Duke) and one year (Butler, Sherifali), one 
did not report these statistics (Armstrong) and one study revealed that 27% of their 
participants’ had been diagnosed in the past year, but this was not explored further (Davis).  
 
Two studies (Jaser, Butler) singularly investigated maternal parenting style, with the 
remaining eight studies measuring both paternal and maternal parenting styles. However, 
only nine studies directly examined parents (fathers and/or mothers) in their study (Shorer, 
Armstrong, Duke, Davis, Lewin, Jaser, Sherifali, Butler, Greene), resulting in one study 
collecting their parental data from the perspective of the child/adolescent (Faulkner). Of the 
final ten studies, only four reported the average parental age; working out as 42.2 years 
across the studies (Jaser, Butler, Sherifali, Greene) and six did not report any results 
regarding the age of parents (Shorer, Duke, Faulkner, Davis, Lewin, Armstrong). In addition, 
it appeared that parents’ education level varied markedly between the studies; one study 
reported that the majority of their sample had achieved approximately 14 years of education 
(Faulkner); three studies indicated their parent sample had mostly attained between 14 to 18 
years of education (Jaser, Sherifali, Greene); one study stated that the majority of its sample 
had achieved 18 plus years of education (Butler) and the remaining five studies did not report 
these statistics (Shorer, Duke, Davis, Lewin, Armstrong).  
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Family income and socio-economic status was not reported in two studies (Faulkner, Butler) 
and in the remaining eight studies it was reported in many different formats which could not 
be grouped together (Shorer, Armstrong, Duke, Davis, Lewin, Jaser, Sherifali, Greene).  
 
Of the ten studies reviewed, six excluded young people with co-morbidities and mental health 
difficulties (Shorer, Armstrong, Davis, Faulkner, Jaser, Sherifali) and four did not mention 
this factor (Duke, Lewin, Butler, Greene). Eight studies excluded young people with 
intellectual disabilities (Shorer, Armstrong, Duke, Davis, Faulkner, Lewin, Jaser, Sherifali) 
and two made no mention of this variable (Butler, Greene). 
 
Research Design 
Nine studies employed a cross-sectional design and employed self-report data collection 
methods (Shorer, Armstrong, Duke, Davis, Faulkner, Lewin, Jaser, Sherifali, Butler). The 
tenth study used a retrospective correlational design, whilst also utilising self-report data 
(Greene). One study used an additional observational method (Jaser) and two studies utilised 
an additional structured interview (Duke, Lewin). It should be noted that although of cross-
sectional nature, one study (Armstrong) made use of participants from the baseline of a larger 
randomised control trial, which is currently unpublished. Furthermore, readers must be aware 
that only two of the studies used a power calculation to determine sample size (Sherifali, 
Faulkner); hence, the results from the eight remaining studies may be unreliable due to lack 
of power. 
Treatment Modality 
Only four of the final ten studies reported the type of T1D treatment that participants were 
receiving (Shorer, Armstrong, Faulkner, Jaser), for example, Insulin Pump Therapy or 
Multiple Daily Injections. This was a concerning finding, as research indicates that the form 
of treatment a young person receives can have a substantial difference on both their level of 
adherence and quality of life (Huang et al., 2007). Hence, we must be cautious in our 
interpretation of the generalizability of these findings to all young people on various forms of 
T1D treatment.  
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Measures Assessing Glycaemic Control  
Objective measures of glycaemic control were utilised in nine studies; five used HbA1c 
(Shorer, Duke, Faulkner, Lewin, Jaser), three used A1c (Armstrong, Sherifali, Greene), one 
used GHb assay (Davis) and one did not use an objective measure (Butler). Due to the nature 
of the measures, the values could not be collated. 
 
Measures Assessing Adherence to SMTR  
Seven studies utilised one self-report measure of SMTR adherence (Shorer, Armstrong, 
Davis, Jaser, Butler, Sherifali, Greene), one study used two self-report measures (Faulkner), 
and the final two studies applied structured interviews (Duke, Lewin). Within the studies, a 
variety of self-report measures were employed and one structured interview, as revealed in 
Table 1 and described below. For information regarding the psychometric properties of the 
described measures, please refer to appendix 1.4. 
 
The Self-Care Inventory (La Greca et al., 1990) was employed by three separate studies 
(Armstrong, Butler, Davis), due to its excellent validity and reliability scores for this 
population. It focuses on items such as blood glucose monitoring, insulin and food regulation, 
exercise and emergency precautions (e.g. carrying sugar to treat reactions). In addition, two 
studies (Jaser, Sherifali) employed The Pediatric Quality of Life Inventory (Varni et al., 
2003), which assesses five main areas: diabetic symptoms, treatment barriers, treatment 
adherence, worry and communication. Two further self-report measures were utilised; 
Faulkner employed the Self-Care Questionnaire (Saucier and Clark, 1993) and Greene 
developed their own measure called The Diabetes Self-Care Instrument. Largely, all the self-
report measures referred to in this review reported good internal consistency and validity, 
with the exception of the Adherence to Diabetes Treatment Regime Questionnaire (Tom-
Katzav, 2007) used by Shorer. Little is known about this measure as it appears to be 
unpublished and no description accompanies it in the study. Hence, caution should be taken 
when interpreting the results from this study. 
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The Diabetes Self-Management Profile (Harris et al., 2000) is a structured interview, which 
assesses five areas of diabetes management, including: insulin administration/dose 
adjustment, blood glucose monitoring, exercise, diet and management of hypoglycaemia. 
This measure was used in two studies (Duke, Lewin) and appears to have good internal 
consistency and inter-observer agreement, lending credence to its use in this population. 
 
Parenting Measures 
Nine of the studies utilised self-report measures to determine parenting style and one study 
adopted an observational measure (Jaser). These self-report measures varied greatly, however 
three studies (Armstrong, Duke, Lewin), used the ‘negative parenting’ subscale of the 
Diabetes Family Behaviour Checklist (Schafer et al., 1986). Furthermore, the sub-scales 
‘warmth and caring’ and ‘guidance and control’ of the Diabetes Family Behaviour Scale 
(Waller et al., 1986) was employed in three studies (Duke, Faulkner, Lewin). In addition, 
Butler adopted the Child/Parent Report of the Parent Behaviour Inventory (Schaefer, 1965a, 
1965b) which is a long-standing measure of parenting. These three scales also appear to show 
good internal consistency and reliability levels. It should be noted, however, that these 
measures were not developed specifically to map onto Baumrind’s (1966) concept of 
parenting styles, but do nevertheless measure aspects of parenting styles which relate to these 
labels (Anderson, 2011). 
 
Four studies (Shorer, Greene, Sherifali, Davis) used three different self-report measures 
which directly modelled on Baumrind’s typology of parenting style. Shorer and colleagues 
(2011) used the Parental Authority Questionnaire (Buri, 1991), Greene and colleagues (2010) 
used the 62-item Parenting Practices Report (Robinson et al., 1995), and Sherifali and 
colleagues (2009), along with Davis and colleagues (2001) used The Parenting Dimensions 
Inventory (Power, 1993). All of these measures reported high internal consistency, reliability 
and validity. 
 
Jaser and Grey (2010) utilised an observational measure; The Iowa Family Interaction Rating 
Scale (Melby and Conger, 2001). This is a well-established and widely used global coding 
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system which is applicable across different cultures, ethnicities and paediatric populations, 
whilst retaining good inter-rater reliability (Alderfer et al., 2008). For further information 
regarding the psychometric properties of the above measures, please refer to appendix 1.4. 
 
 
Findings  
Each of the ten studies included in this review addressed the influence of parenting style on 
adherence to young people’s SMTR, with nine investigating the influence of parenting style 
on young peoples’ glycaemic control (Shorer, Armstrong, Duke, Davis, Faulkner, Lewin, 
Jaser, Sherifali, Greene).  
 
Parenting style and glycaemic control 
Of the nine studies (Shorer, Armstrong, Duke, Davis, Faulkner, Lewin, Jaser, Sherifali, 
Greene) which investigated the influence of parenting style on glycaemic control, seven 
stated that an authoritative parenting style was related to better glycaemic control (Shorer, 
Duke, Davis, Faulkner, Lewin, Jaser, Greene). They also reported that authoritarian and/or 
permissive parenting styles were related to poorer glycaemic control. Conversely, two studies 
(Armstrong, Sherifali) found that parenting style had no impact on glycaemic control within 
their population. It is of interest that both of the studies which did not report a correlation 
between parenting style and glycaemic control were within child populations. In addition, no 
difference was found between paternal and maternal parenting styles and glycaemic control. 
 
Parenting Style and Adherence 
All of the ten studies investigated the influence of parenting style on adherence to the SMTR. 
Of these, seven studies found that an authoritative parenting style improved adherence 
behaviours, whereas an authoritarian or permissive style decreased adherence behaviours 
(Shorer, Duke, Davis, Faulkner, Lewin, Jaser, Greene). This finding stood for both paternal 
and maternal parenting. It should be noted, however, that Lewin and colleagues (2006) only 
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found this association in older children. Three studies found that parenting styles had no 
impact on adherence behaviours (Armstrong, Sherifali, Butler).  
 
Discussion 
This is the first systematic review to examine the relationship between parental style and 
adherence and glycaemic control in young people with T1D. Ten studies have been reviewed 
and the findings will now be discussed in relation to the objectives of this review. 
 
Parenting Adolescents with T1Ds 
Overall, the evidence appears to support the use of an authoritative parenting style when 
parenting adolescents with T1D (Shorer, Duke, Davis, Faulkner, Lewin, Jaser, Greene). This 
form of parenting seems to result in superior glycaemic control and improved adherence to 
their SMTR. One hypothesis is that parents who employ an authoritative parenting style 
engage in certain behaviours, such as providing rewards, giving regular positive feedback and 
planning self-care activities with the adolescent; these parenting behaviours are thought to 
promote increased glycaemic control and improved adherence behaviours. This form of 
parenting appears to work particularly well with adolescents who are beginning to take 
responsibility for their own diabetes management, but still need a degree of support (Palmer 
et al., 2009). This is in contrast to parents who are perceived as critical and authoritarian, 
these parenting behaviours appear to lead to a decrease in adherence behaviours and poorer 
glycaemic control. One explanation for this influence is harmonious with Patterson’s 
coercion model (Patterson, 1982). This suggests that if parents are perceived as critical then 
young people may resist parental control by engaging in non-adherent behaviour, which has a 
subsequent impact on glycaemic control (Borus and Laffel, 2010). This results in families 
feeling trapped in a power struggle, which subsequently influences family functioning and 
diabetes-related behaviours. 
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Parenting Children with T1Ds 
Despite the clear evidence supporting the link between parenting style and adolescents’ 
glycaemic control and adherence behaviours, the evidence remains inconclusive in relation to 
younger children/pre-adolescents. The dominant explanation for the lack of relationship 
between parenting style and glycaemic control/adherence behaviours, is that for younger, pre-
adolescent children, parents are still responsible for the majority of diabetes-related tasks and 
so children are not expected to take on the self-management of their treatment regime (Patton 
et al., 2011). Hence, critical parenting has less of a direct impact on the child’s diabetes. 
However, there is some evidence to support the relationship between an authoritative warm 
parenting style and improved adherence behaviours in children as young as four years old 
(Davis). Despite this, the evidence for younger children remains inconclusive due to the 
paucity of research in this population. 
 
Methodological limitations and Future research 
The studies in this review all received overall ratings of moderate to high quality but this does 
not mean they did not have methodological shortcomings. Firstly, all the studies were of a 
correlational design and so directional causation was only hypothesised, not determined. For 
example, the reviewed studies lead the reader to believe that authoritative parenting leads to 
better T1D self-management and glycaemic control. Whereas it could be the converse that is 
true; better glycaemic control and optimal adherence behaviours may be associated with 
higher levels of compliance in the adolescent, which in turn could make it easier for parents 
to employ an authoritative parenting style. Furthermore, the parent-child attachment style was 
not investigated in any of the included studies. Hence, it would be of interest for future 
research to examine attachment style to investigate whether authoritative parenting is a 
reflection of an attuned attachment relationship. 
 
The generalizability of the studies was questionable as all bar one of the studies (Shorer) 
were carried out in Western Societies, limiting their relevance to other cultures and 
ethnicities. Furthermore, the majority of studies indicated that their small sample size was of 
concern as this unveiled the possibility that they did not have the power to support their 
findings, especially given that only two of the studies conducted a power analysis. The 
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information gained here provides a starting point for a larger multi-site study with a more 
diverse sample of ethnic and socioeconomic statuses. 
 
The type of T1D treatment participants were receiving was not controlled for, or even 
reported in most studies. This was despite the evidence which indicates that certain treatment 
regimes are easier to adhere to and achieve greater glycaemic control than others (Huang et 
al., 2007). To accurately reflect the relationship between glycaemic control, adherence 
behaviours and parenting style, future studies should control for the type of T1D treatment. In 
particular, future research should consider investigating the parenting styles of families with 
children/adolescents on a low number of injections and comparing this to those families with 
children/adolescents on multiple daily injections. 
 
Additionally, it should be noted that no restrictions were applied to the included studies 
regarding the length of time since diagnosis of T1D. This is an important caveat to consider 
as we cannot ascertain if the results may have been influenced by the ‘honeymoon phase’ 
phenomenon, which states that patients may experience a period of time in which they are in 
partial remission and have good glycaemic control shortly after diagnosis (Abdul-Rasoul et 
al, 2006). Hence, future studies need to control for the time since diagnosis in order to reduce 
confounding factors. 
 
The studies reviewed included young people ranging in age from four years old to eighteen 
years old. Hence, this review tried to collate the results of all the young people, whilst taking 
into consideration the studies which only examined children or adolescents. Consequently, 
this review spanned two developmental periods which authors have suggested are separate 
and distinct from one another and as such should not be classified together (Ross et al., 
2011). Hence, future reviews should take this into consideration and should consider 
comparing young people by developmental stage.  
 
 
The majority of studies utilised self-report measures, which are inherently associated with 
biases, primarily due to socially desirable responding. Consequently, future studies should 
look to include a range of measures including an observational measure and measures with 
multiple informants, specifically investigating both maternal and paternal parental styles in 
order to increase the reliability of the results. 
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The three studies which did not find a relationship between parenting style and adherence 
and/or glycaemic control, indicated that this may be due to most of their sample rating 
themselves as authoritative and so it is possible that the lack of extremes in parenting may 
have influenced their lack of findings (Armstrong, Sherifali, Butler). Once again, this 
suggests a socially desirable bias in respondents, and/or a homogenous sample, which may 
not be representative of the population as a whole. 
 
 
Clinical implications  
The generic parenting literature supports an authoritative parenting style in order for children 
to develop appropriate autonomy and mastery over tasks (Spera, 2005). This review further 
examines the importance of applying this parenting style to chronic illnesses such as T1D in 
order to achieve optimal health. The findings demonstrate the importance of helping parents 
to be involved with their children’s diabetes care in a non-critical way, to increase adherence 
to their SMTR and improve glycaemic control. It seems it is the quality of these interactions 
and support that is of vital importance to young people with T1D. Hence, the evidence 
suggest that it may be beneficial to devise a brief preventative approach aimed at providing 
parents with information on how to stay involved using authoritative, supportive parenting 
and reduced critical parenting behaviours. These prevention programs must be introduced at 
an early age in order to minimise difficulties in adolescence and could be included as part of 
the current structured education program which is delivered to all children and adolescents 
with T1D alongside their parents, as recommended by the Scottish Intercollegiate Guidelines 
Network (2010) and National Institute for Clinical Excellence (2004) guidelines.  
 
Currently the research is unclear regarding which theoretical approach to apply. Some studies 
have recommended utilising a Behavioural Family Systems Therapy (Wysocki et al., 2007) 
approach with a focus on specific diabetes family functioning such as communication and 
overcoming conflict (Butler, Lewin, Duke). Evidence is limited, however, indicating the need 
for prospective, randomised controlled trials to test these interventions. Furthermore, the 
introduction of targeted individual strategies for improving shared responsibilities in daily 
routines for insulin administration, diet and exercise would be beneficial, especially when 
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children are maturing and reaching adolescence. However, it would be beneficial to consult 
patients and their parents to investigate which approaches are most acceptable. 
 
 
Conclusions 
Overall, the findings from this review highlight the importance of parental style. The use of 
an authoritative parenting style when parenting adolescents’ with T1D is vital, in order to 
encourage adherence to their diabetes SMTR and to achieve optimal glycaemic control. The 
evidence in regards to children/pre-adolescents is inconclusive, but it would seem prudent to 
assess parenting practices and if required, teach parents how to use authoritative parenting as 
a part of their repertoire. Further research is required to develop effective parenting education 
programs, which focus on promoting self-management adherence behaviours with young 
people. 
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Lay Summary 
 
Type 1 diabetes (T1D) is a long-term condition which requires daily treatment with insulin in 
order to prevent severe health problems and even death. In the past, T1D was treated with 
insulin injections; however, recent advances in technology have resulted in insulin being able 
to be given via a pump. Some research shows that the insulin pump has many benefits such as 
improving people’s quality of life (QoL) and their control over their condition, however, 
other research does not find this. The aim of this study was to explore the impact of Insulin 
Pump Therapy on the QoL of young people. Interviews were carried out with eight young 
people (aged 8-13) with T1D, at the Royal Hospital for Sick Children, NHS Greater Glasgow 
& Clyde. The interviews were recorded and typed out word for word. They were then read 
over a number of times and themes searched for. Six themes were found: 
‘Physical Impact’, ‘Mood and Behaviour’, ‘Lifestyle Flexibility’, ‘Practicalities’, ‘Peer 
Reactions’, and ‘Support’. Together, these themes showed that most of the participants found 
that switching to Insulin Pump Therapy resulted in improvements to their QoL and so they 
were happy to be using the pump. A number of recommendations have been made and areas 
for future research have been outlined. 
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Abstract 
 
Introduction: Insulin Pump Therapy has gained worldwide acceptance for the treatment of 
Type 1 diabetes mellitus (T1D), offering a new method of insulin delivery, which 
circumvents the need for Multiple Daily Injections (MDI). It is thought to improve quality of 
life (QoL) by facilitating an increase in lifestyle flexibility, independence and glycaemic 
control (Scottish Intercollegiate Guidelines Network, 2010; National Institute for Clinical 
Excellence, 2008). These benefits have resulted in the National Health Service (NHS) 
Scotland pledging funding of at least £1million to deliver insulin pumps to under 18s 
(Scottish Government, 2012).  Currently, investigations regarding the impact of Insulin Pump 
Therapy on QoL have resulted in conflicting findings (Barnard et al., 2007). This study aims 
to explore the impact of Insulin Pump Therapy on the QoL of children and adolescents, using 
Interpretative Phenomenological Analysis. 
Method:  Eight participants with T1D, aged between 8 and 13 years and using an insulin 
pump, were recruited from the Glasgow Royal Hospital for Sick Children Diabetes Clinic. 
Each participant completed an in-depth interview, which explored their beliefs and attitudes 
towards Insulin Pump Therapy including its impact on their QoL. 
Results: Analysis of the transcripts led to the identification of six super-ordinate themes: 
‘Physical Impact’, ‘Mood and Behaviour’, ‘Lifestyle Flexibility’, ‘Practicalities’, ‘Peer 
Reactions’, and ‘Support’. It is suggested that these six factors are not mutually exclusive and 
together inform the complexity of individuals’ experiences and the impact that the insulin 
pump has had on many aspects of their lives. These findings suggest a framework to help 
clinicians understand how young people with T1D perceive and conceptualise their treatment 
regimes. 
Conclusions: There was general agreement amongst participants that switching to Insulin 
Pump Therapy resulted in improvements to their QoL. Additional concerns were outlined but 
reportedly none of the participants regretted switching to an insulin pump. 
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Introduction 
 
Background 
Insulin Pump Therapy, also known as Continuous Subcutaneous Insulin Infusion (CSII), has 
gained worldwide acceptance in the treatment of Type 1 diabetes mellitus (T1D). It offers a 
new method of insulin delivery, which omits the need for Multiple Daily Injections (MDI). 
Current national recommendations advise the use of Insulin Pump Therapy for those with 
very low insulin requirements (such as infants and very young children) and for all patients 
who experience recurring episodes of severe hypoglycaemia (Scottish Intercollegiate 
Guidelines Network, SIGN, 2010). It has also been endorsed by the National Institute for 
Clinical Excellence (NICE, 2008), who report that it has the potential to improve quality of 
life (QoL) by increasing lifestyle flexibility and offering greater independence, as well as 
improving patients’ glycaemic control. Given the rising incidence of T1D in Scottish children 
over the last 30 years and the apparent QoL benefits the insulin pump can offer, the Scottish 
Government has pledged funding totalling one million pounds to help provide Insulin Pump 
Therapy to under 18s with T1D (NHS Scotland, 2009; SIGN, 2010; Scottish Government, 
2012). 
 
Insulin Pump Therapy 
Conflicting findings have been identified in relation to the impact of Insulin Pump Therapy 
on patients’ QoL with regard to adult and child/adolescent populations. The authors of a 
recent systematic review tentatively suggested that these conflicting findings were the result 
of variations in study quality and the QoL assessments used (Barnard et al., 2007).  
 
It is only in recent years that qualitative approaches have been utilised to explore the impact 
of Insulin Pump Therapy on QoL (Barnard and Skinner, 2007). Qualitative approaches 
address certain methodological flaws, such as reduced measure sensitivity, as demonstrated 
in the Diabetes QoL questionnaire (Jacobsen et al., 1988), yet they are underrepresented and 
to date, have not focused exclusively on young people (Barnard and Skinner, 2007). The 
accumulating qualitative evidence appears to indicate that changing from MDI to Insulin 
Pump Therapy in adulthood can present challenges in the short-term but over an extended 
period, it is associated with a significant improvement in QoL for the users (Todres et al., 
2010).  
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Children and adolescents 
Late childhood to early adolescence is known to be a complex transitional period in which a 
variety of physiological and psychosocial changes are occurring; this can result in a decrease 
in the body’s sensitivity to insulin (Silverstein et al., 2005). Concurrently, developmental 
needs such as the desire for social acceptability, independence and identity formation can 
interfere with diabetes treatment adherence (Hamilton and Daneman, 2002). These adolescent 
changes are of vital importance and merit exploration. Hence, this study focuses on young 
people in the developmental period that occurs between ages 8-13 years old. 
 
 
Quality of Life 
Quality of life is a multifaceted dynamic concept and as such, there is currently no uniform 
definition. Many authors have tried to conceptualise QoL and after much discussion within 
the research team, for the purpose of this study, we look to Joyce (1994) who stated that QoL 
is “what the patient says it is”. This view emphasises the subjective nature of this 
psychological outcome and tries to capture what is important to the individual, as opposed to 
what others think is important. Further, it was felt that the broadness of this definition was 
helpful when working with children and adolescents, unlike many other specific terms such 
as that defined by the World Health Organisation (1997), which target an adult population 
with differing needs and desires to obtain a good QoL. In addition, this person-centred 
definition reflects the form of analysis employed; Interpretative Phenomenological Analysis 
(IPA) as it puts the individual at the centre of the question and allows them to define what 
make for a good QoL. 
 
 
Aim 
This study will use IPA to explore young peoples’ perspectives regarding the impact that 
Insulin Pump Therapy has on their QoL. It is hoped that this study will address some of the 
gaps within the current research and provide a framework for future investigation and 
analysis. 
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Method 
 
Ethics 
Prior to the study commencing, ethical approval was granted by the West of Scotland 
Research Ethics Committee (Appendix 2.2) and the Clinical Governance body within NHS 
Ayrshire and Arran. Data was handled in accordance with the Data Protection Act (1998), the 
Freedom of Information (Scotland) Act (2002) and the NHS Confidentiality Code of Practise 
Guidelines (2003). Practice was informed by the British Psychological Society Code of 
Ethics & Conduct (2009). 
 
Design 
This study utilised a retrospective qualitative design with in-depth interviews. Concerns 
regarding the reliability of retrospective memory were noted, with particular emphasis on 
recall bias (Moss & Goldstein, 1979).  Accumulating evidence, however, suggests that 
retrospective reporting is typically factually accurate, especially when an individual is 
recalling a salient experience such as changing treatment regime (e.g. Blane, 1996; Norris et 
al., 1992). 
 
Recruitment and Participants 
Purposive sampling was used to recruit young people from a regional children’s hospital 
between October 2011 and February 2012. The Clinical Nurse Specialist identified patients 
who fully met the inclusion criteria and none of the exclusion criteria (see Table 1). For 
information on the hospital criteria to determine eligibility for Insulin Pump Therapy please 
see Appendix 2.3. 
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Table 1: Inclusion and Exclusion Criteria 
 
Inclusion Exclusion 
 Diagnosis of T1D as specified by their 
Consultant and in line with the WHO 
(2006) criteria  
 
 Between the age of 8 and 15  
 
 Duration on Insulin Pump Therapy: 
between 6 months to 3 years.  
 
 Prior to starting Insulin Pump Therapy 
must have been on MDI for a minimum 
of 6 months 
 
 Attend the diabetes clinic at a regional 
children’s hospital. 
 Non-English speaker 
 
 Presence of a learning disability 
 
 Any additional medical illness (mental or 
physical) 
 
 
The Clinical Nurse Specialist contacted the first eight participants on the clinic list (and their 
parent/guardian) via telephone, inviting them to participate in the research study. All eight 
participants gave permission for their contact details to be passed on to the principal 
researcher. An information sheet was sent to participants and their parents/guardians and an 
appointment was subsequently arranged at a mutually agreeable time. A flow diagram 
outlining recruitment is detailed in Figure 1. Prior to the interview, all participants and their 
parent/guardian were asked to provide written informed consent and had the opportunity to 
ask further questions. The information sheets and consent forms can be viewed in Appendix 
2.4. 
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Figure 1: Flow diagram for participant recruitment 
 
 
 
The final sample of eight participants achieved data saturation. This is in line with Guest and 
colleagues (2006) who report that a minimum of six to a maximum of twelve interviews are 
required to facilitate data saturation and allow the researcher to explore participants’ 
narratives in depth and gain a greater understanding of their experiences. Furthermore, as 
recommended by Smith and Osborn (2003), the participants in this study represented a 
reasonably homogenous, purposive sample. Hence, six females and two males were 
interviewed, all White Scottish, aged between 8 - 13 years old. It should be noted that there 
was a wide-range of deprivation scores, indicating a range of socioeconomic statuses 
amongst participants. Participant characteristics can be found in Table 2. In order to protect 
their anonymity, participants will be referred to by numbers. 
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Table 2: Participant Characteristics 
 
Participant 
Age at 
Interview 
(year & 
month) 
Gender 
Scottish Index  
of Multiple 
Deprivation 
Decile 
(2009/10)
2 
Age at T1D 
diagnosis 
(years) 
MDI 
Experience 
(years) 
Insulin 
Pump 
Experience 
(years) 
1 11.1 Female 3 5 3.5 2.5 
2 13 Male 9 7 5 1 
3 8.8 Female 7 4 3 1.5 
4 8.1 Female 5 5 1.5 1.5 
5 12.2 Male 7 6 4 2 
6 13.4 Female 8 9 1 3 
7 13.7 Female 8 7 5 1.5 
8 8.6 Female 1 2.5 4.5 2 
 
 
Interview Procedure 
Individual, semi-structured interviews were conducted with young people, utilising open-
ended and non-directive questioning. This was to encourage participants to reflect on their 
thoughts, feelings and experiences regarding the impact Insulin Pump Therapy has had on 
their lives compared to their previous treatment (MDI). Areas to be explored were identified 
within the interview schedule. This schedule was developed through discussion with the 
research team using the Common Sense Model of Self-regulation of Health and Illness as a 
theoretical framework to support participants’ reflective engagement (Leventhal et al., 1984) 
(see Appendix 2.5). This model was used in order to provide a structure and fluidity to the 
interview, which the QoL literature was unable to achieve. This schedule was not prescriptive 
in its nature, its main purpose was to guide the interviewer and provide prompts, without 
explicitly controlling the direction of the interview. The topic guide was piloted with a subset 
of the sample (n=3) to assess the appropriateness of the topic areas. 
 
                                                 
2 The Scottish Index of Multiple Deprivation (SIMD) provides a relative ranking of the deprivation data zones in Scotland, based on a 
weighted combination of data in the domains of Current Income, Housing, Health, Education, Skills and Training, Employment and 
Geographic Access and Crime (no Crime data available for SIMD 2004). An overall relative ranking score can be assigned; decile 1 is the 
most deprived 10% of Data Zones and decile 10 is the least deprived 10% of Data Zones. 
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Following analysis of the pilot interview transcripts, revision of the topic guide was not 
deemed necessary and the three pilot participants were included in the main study sample. 
Interviews were conducted in a private room within the hospital grounds. The interviews 
lasted between 30 and 50 minutes, were audio recorded, transcribed verbatim and 
anonymised for reference to person or place. The recordings were stored on an encrypted 
laptop and when transcription was completed and checked, each recording was destroyed. 
 
 
Data Analysis 
Interpretative Phenomenological Analysis was employed to analyse these data. The six phase 
process as described by Smith and colleagues (pp. 82-103, 2009) was followed (summarised 
in Table 3). This enabled the researcher to gain an ‘insider’s perspective’ of the participants’ 
individual experiences, whilst taking into consideration the principal researcher’s own 
thoughts and feelings (Smith and Osborn, 2003). A sample transcript and initial coding can 
be seen in Appendix 2.6. 
 
Table 3: Six-stage analytical procedure  
 
Stage Description 
1 
Reading and re-reading 
Each transcript was reviewed a number of times in order to gain a contextual and holistic 
understanding of the entire narrative.  
2 
Initial coding 
Each interview was explored and examined for semantic content and language. 
3 
Developing emergent themes 
Exploratory comments and coding were analysed to identify emerging themes. 
4 
Searching for connections across emergent themes 
Charting or mapping how the themes fit together. 
5 
Moving to the next case 
Repeating steps 1-4 for the rest of the transcripts. 
6 
Looking for patterns across cases 
Identifying the most illuminating themes and how they inter-connect across participants’ 
transcripts. 
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Reflexivity 
A vital aspect of IPA is the researcher’s awareness of their own experiences, bias, attitudes 
and beliefs, and recognising how this may influence their data interpretation (Reid et al, 
2005). This is referred to as reflexivity and it is important to acknowledge these influences 
within this study. The principal researcher is a 27-year-old female who does not have T1D, 
nor does she have any close family members or friends with T1D. She has, however, worked 
within a medical paediatric setting and worked individually with young people who have 
T1D. Consequently, she had some prior knowledge and insight into some of the challenges 
and barriers that this client group face. In recognition of the potential for bias in 
interpretation, a random sample of three transcripts were independently analysed by a second 
researcher; a Psychologist, aged over fifty, experienced in the use of IPA, who had no prior 
interaction with the members of this patient group, either professionally or personally. A high 
level of agreement between analysts was found for the themes identified, which supports the 
reliability and validity of this research. 
 
 
Results 
 
Of the eight potential participants approached, all agreed to take part and there were no 
concerns regarding retrospective memory, suggesting that the topic under investigation is 
particularly salient for them all. Throughout the interviews, the participants did not appear 
distressed by the content; in fact, many of them commented that they had enjoyed the 
experience. It seemed that partaking in this research study activated a process of reflection for 
most participants, where they seemed to be developing their own personal story about their 
experiences. This led to the emergence of a number of themes, many of which were 
recounted by multiple participants.  
 
Six super-ordinate themes were identified which aligned themselves alongside participant 
experiences with both the pre- multiple daily injections (MDI) and their current insulin pump 
treatment regime. The themes are identified in Table 4.  
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Table 4: Table of emergent themes 
 
Super-ordinate Themes 
 
MDI Themes and Sub-
themes 
 
Insulin Pump Themes and 
Sub-themes 
1. Physical Impact 
Negative physical impact: 
 
i. Pain 
ii. Visible scarring 
iii. Distressing 
iv. Poor glycaemic 
control 
 
Reduced physical impact: 
 
i. Less Pain 
ii. Hidden scarring 
iii. Cannula 
iv. Improved glycaemic 
control 
 
2. Mood and Behaviour 
Negative impact: 
 
i. High frequency of 
injections 
ii. Uncontrolled blood 
glucose levels 
iii. Negative feelings 
towards injections 
Positive impact: 
 
i. Less frequent 
injections 
ii. Controlled blood 
glucose levels 
iii. No need for 
injections 
3. Lifestyle Flexibility 
 
Negative impact on: 
 
i. Eating 
ii. Exercise 
iii. Social life 
iv. Sleep 
v. Routine 
 
Positive impact on: 
 
i. Eating 
ii. Exercise 
iii. Social life 
iv. Sleep 
v. Routine 
 
4. Practicalities 
i. Convenience 
ii. Practical problems 
i. Convenience 
ii. Practical problems 
iii. Visibility 
 
5. Peer Reactions 
N/A 
 
i. Positive reactions 
ii. Negative reactions 
6. Parental Support Parental burden Parental support 
 
 
 
SUPER-ORDINATE THEME 1: ‘PHYSICAL IMPACT’ 
 
The majority of participants’ identified the physical impact of their treatment regime as 
having a significant impact on their QoL. This gave rise to two sub-themes: (i) the negative 
physical impact from MDI and (ii) the reduced physical impact from Insulin Pump Therapy. 
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MDI - Negative physical impact 
 
i. Pain 
It appeared that the MDI’s were aversive due to four reasons. Firstly, participants reported 
that the injections caused a lot of pain: 
 “I don’t know, maybe just cause I was getting so much of it at a time I was just getting really 
sore”. 
[Participant 7, P2: L52] 
 
Although some participants remarked that they got used to the pain: 
 
“Well, when you get diabetes you have to get injections first, but then it’s quite sore at first 
but when you get used to all the finger pricks and all the injections that you get, it’s not as 
sore”. 
[Participant 4, P1: L8] 
 
ii. Visible scarring 
Secondly, participants described in detail the visible affect it had on their bodies: 
 
“You had bruises all over and I didn’t really like seeing blood all over it”. 
[Participant 4, P15: L312] 
 
“I got big red marks and they were itchy and sore and having loads of them on your legs was 
just a pain”. 
[Participant 6, P9: L156] 
 
iii. Distressing 
Thirdly, a few participants also commented that they found the thought of injecting 
themselves on multiple occasions throughout the day distressing: 
 
“Yeah, it’s just like the thought of like a needle going into me. I’ve never liked needles”. 
[Participant 1, P2: L42] 
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iv. Poor glycaemic control 
Fourthly, participants stated that they struggled to gain control over their blood glucose levels 
and experienced many more hypoglycaemic and hyperglycaemic events: 
 
“It was high and then it went to low. It was only, em, and when I had that at school I had 
loads of hypo’s”. 
[Participant 4, P3: L60] 
 
 
Insulin Pump Therapy – Reduced physical impact 
 
i and ii.  Less pain and Hidden scaring 
As described above, all participants remarked on the negative affect of MDI on their bodies 
and frequently compared this with the lesser impact from their insulin pump. This perceived 
physical improvement appears to mirror the previous MDI factors of pain and the visibility of 
the scarring: 
 
“Yeah, my legs are fine and you just need to put your cannula in, you just need to give 
alternative, I put my cannula in my stomach so I just need to move about and it’s definitely 
not as sore cause I mean in three days when I was on injections I was doing all my injections 
on my stomach. I was doing fifteen, all of them tiny, tiny holes, but fifteen in me. Now I’ve 
only got one compared to fifteen. So, my stomach can, it’s much better”. 
 [Participant 2, P7: L120] 
 
 
iii.  Cannula 
It should not be overlooked, however, that the insulin pump can also cause physical 
difficulties. Primarily it seems due to cannula insertion and the positioning of the pump: 
 
“Em, well when you’re on injections it makes your legs all lumpy and bruised, and it does the 
same to your stomach when you are on cannula changes”. 
[Participant 1, P2: L24] 
 
 
45 | P a g e  
 
“Well, it nips me…. Like a dog. Well not my dog cause it doesn’t nip, but like a Jack Russell 
cause every time you move it, it nips you and there’s a big mark on your hip… It’s sore”. 
[Participant 4, P13: L270] 
 
 
iv.  Improved glycaemic control 
Furthermore, participants revealed the insulin pump had improved their glycaemic control to 
a more manageable level, although it was still not perfect: 
 
“And the pump, I can live a, two days or more of maybe having perfect blood sugars and then 
the odd high maybe and then come back down…But it’s, I don’t get as many highs on the 
pump”. 
[Participant 2, P3: L64] 
 
 
SUPER-ORDINATE THEME 2: ‘MOOD AND BEHAVIOUR’ 
 
A common theme which arose was the impact that treatment regime can have on participants 
mood and subsequent behaviour. All of the participants divulged that they struggled to 
maintain a positive mood whilst on MDI, primarily due to three reasons: (i) frequency of 
injections, (ii) uncontrolled blood glucose levels and (iii) not wanting an injection. It appears 
that when these factors were removed via Insulin Pump Therapy, participants observed an 
improvement in their mood and behaviour. 
 
 
i. High vs. Low Frequency of Injections 
 
The frequency of the injections was often cited as a major influencing factor on participants 
mood. Within this theme, participants reflected that it was the quantity of injections when 
using MDI which had the most significant impact on their mood. Conversely, it was the 
removal of this factor on the Insulin Pump Therapy which improved their mood: 
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“Yeah, yeah. I probably felt more angry when I was on injections cause it was harder then 
cause we had to do loads of injections instead of just once every two days. And so I was 
probably angrier then but now it’s more relaxed I think having the pump”. 
[Participant 3, P14: L316] 
 
 
ii. Uncontrolled vs. Controlled blood glucose levels 
 
Secondly when their blood glucose levels were uncontrolled on MDI, participants 
commented that their mood was more negative. In contrast, on the insulin pump, their blood 
glucose levels were more controlled which resulted in their mood improving: 
 
“When I’ve been on injections and that I used to get really moody if my blood sugars were 
high and get in a mood or really angry, and I’ve only had that once since I’ve been on the 
pump and I used to have that once a month when I was on the injections, and now it’s been 
only once since I’ve been on the pump…. I’ve just never”. 
[Participant 2, P4: L74] 
 
 
iii. Feelings towards injections 
 
Thirdly, participants reported that they simply did not want to have an injection and described 
behaviours such as hiding and pushing their parents away: 
 
“I’d run and hide in the bathroom and lock the door. Like there was one time when I stayed 
in there for like half an hour, an hour”. 
[Participant 1, P3: L70] 
 
 
“Well, I was kinda pushing them away cause I didn’t really want… Well I wasn’t like pushing 
them, I was just like, I didn’t, didn’t want the injections”. 
[Participant 4, P6: L116] 
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Whereas participants reported that their behaviour and mood on the insulin pump had 
significantly improved: 
 
“Em, just really, you know, happy, cause it’s more, it allows you to do more things that you 
couldn’t do”. 
[Participant 5, P12: L338] 
 
 
It should also be noted that two of the participants described concurrently struggling with 
feelings of frustration with both the MDI and Insulin Pump Therapy: 
 
“Yeah it does, but there have been times that I’ve wanted to go back to injections because it 
does get annoying having to keep having it on, and there have been times that I’ve just ended 
up really angry at it because it is really good in general but I’ve, like the fact when I do then 
do an injection and it doesn’t hurt, and I don’t really, I forget why I went onto it. I’m just like 
I want to go back, just for a week, but then I think no because it would be fine but no, not if it 
was in school. I’d hate that. It would just take up too much time and I don’t like school or 
anyone getting too involved. I don’t like people getting too involved, it just annoys me”. 
[Participant 6, P11: L204] 
 
 
SUPER-ORDINATE THEME 3: ‘LIFESTYLE FLEXIBILITY’ 
 
Participants described a number of factors vital to helping them live a more flexible lifestyle 
and fundamentally cope better with their diabetes. These included the impact on: (i) Eating, 
(ii) Exercise, (iii) Social life, (iv) Sleep and (v) Routine. 
 
 
i. Eating 
 
The majority of participants indicated that on the MDI their lives were often restricted by 
when and what they ate: 
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“So when suddenly like the feeling knowing you can’t eat, like you can’t eat even if you are 
absolutely starving, is horrible, but then when you’re being forced to eat, you’re being forced 
to sit at the breakfast table and you have to eat it, unless you’re gonna go. I didn’t like it”. 
[Participant 6, P3: L52] 
 
 
This is in stark comparison to their food intake whilst on the insulin pump, which seems to 
allow for greater lifestyle flexibility, as participants have more control over when and what 
they eat: 
 
 “On the pump, I would maybe eat what I’m not supposed to eat, I could still control it like I 
would if I would eat something else, like chocolaty or something”. 
[Participant 5, P8: L214] 
 
ii. Exercise 
 
Participants suggested that neither the MDI nor the insulin pump constrained them from 
taking part in activities, but that the increased control over their blood glucose levels when on 
Insulin Pump Therapy allowed them to participate more fully in activities. They attributed 
this to improved energy levels: 
 
“I feel a lot healthier cause I can, now I can, I feel as if I can run faster anyway. I can do 
more activities. It’s not as if it was restricting me but I can do more now, I feel as if I can do 
more now cause I’ve got more energy to do it”. 
[Participant 2, P3: L52] 
 
 
iii. Social life 
 
The majority of participants reported experiencing a negative impact upon their social lives 
whilst on MDI. This extended to school, extracurricular activities and parties: 
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“There was one point where my mum said that she asked all my friends mums not to invite me 
to their parties cause I’d just get so upset”. 
[Participant 1, P4: L84] 
 
“Yeah, and it takes up a lot of time at school, cause you wait in the line, then you have to eat 
your lunch, then you have to go, do an injection, pack it all away, and by the time you’ve 
done that you don’t really have time to see people and say hey and stuff. And then I feel bad, 
cause my friends are obviously gonna come with me but I don’t want them to have like, have 
to wait around with me”. 
[Participant 6, P11: L202] 
 
 
Whereas participants described having better social lives now on the insulin pump: 
 
“Yeah, like going to parties. I can go to parties and I can do what I want now”. 
[Participant 1, P14: L368] 
 
“It’s made it easier cause obviously if we’re out and about and we’re doing something fun, I 
don’t have to be taken to the side to do it. So it has made a difference cause it’s not so much 
hassle, it’s much easier to control”. 
[Participant 6, P18: L334] 
 
iv. Sleep 
 
Participants described frequently being woken up at night when on their MDI in order for 
their parents to adjust their insulin levels. Using the insulin pump, however, if adjustment is 
required, parents can enter the units into the meter without the need for an injection or 
waking their child up: 
 
“I check my blood in the middle of the night…. Yeah, well it’s not actually me who does it, 
it’s mum. She actually gets up and checks it while I’m still asleep… She just checks my blood 
and if it needs corrected she just gets my pump and puts it in”. 
[Participant 7, P12: L356] 
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v. Routine 
 
Participants reflected on the difference that their treatment regime has made to their diabetes 
routines. They unanimously voiced that on the MDI they had a long and often tedious 
routine, which revolved around the frequency of their injections:  
 
“Em, well sometimes it could be around five or six times a day. If it was a day say like 
Christmas Day or New Years Day say when I would be eating a lot, maybe about eight 
injections a day”. 
[Participant 5, P2: L26] 
 
 
This is in contrast to participants’ view of their current routine on Insulin Pump Therapy, 
which can be encapsulated by the following quote: 
 
“Like it’s not, it’s not a routine. That’s what’s good about it”. 
[Participant 1, P11: L274] 
 
 
SUPER-ORDINATE THEME 4: ‘PRACTICALITIES’ 
 
One of the dominant themes to arise from the interviews was the practicalities of the different 
treatment regimes and the degree to which participants found these distressing. There were 
three sub-themes: (i) convenience, (ii) practical problems and (iii) visibility. 
 
 
i. Convenience 
 
The idea that Insulin Pump Therapy was more convenient than MDI was mirrored throughout 
most of the interviews. All of the participants said it was ‘easier’ to administer their insulin 
via the pump, which in turn made their lives easier in general: 
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“Well, it was just, when you are on the pump it’s just so much easier cause for me it was 
just.. unless anything went wrong with your cannula or the site or anything. Em, but it was 
just one injection compared to fifteen which basically means you’re taking away fourteen 
injections from me, if everything goes well”. 
[Participant 2, P2: L48] 
 
 
More specifically, some of the participants said this was due to greater technical control with 
the insulin pump: 
 
“Also the pump is more accurate, than the insulin, em, sorry the pens. Em, say for instance 
the pens can only dial half units, so its half, one, one and a half, two. Instead with the pump, 
you can get 0.1 of a unit”. 
[Participant 5, P9: L248] 
 
“Yeah, cause it’s not like just your head working it out, it’s also like a computer working it 
out for you. So its em, obviously you estimate what it’s gonna be and then it will tell you 
exactly, the exact amounts so it’s usually spot on”. 
[Participant 6, P15: L266] 
 
 
Participants also indicated that they found it easier to learn how to use the insulin pump and 
to maintain this knowledge long-term: 
 
“Well, it took a wee while to get used to it but once you’ve got the hang of it it’s really easy”. 
[Participant 7, P4: L112] 
 
 
Hence, this ease of use was in turn supporting participants’ desire to become more 
independent. In fact, we saw from two participants that they found the insulin pump made 
their lives feel more ‘normal’ to the point they could forget about their diabetes; this was not 
experienced whilst on MDI: 
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“Cause it just allows to do, allows to do what you want to do. With the insulin, you would 
have to follow the rules of the insulin pen, but with the pump you do just whatever you like. 
You take your insulin. You just live a normal life”. 
[Participant 5, P17: L472] 
 
 
Although, it is important to note that this increase in independent diabetes control can be hard 
for parents to come to terms with: 
 
“Yes because sometimes when I want to try and do some of it myself my mum and dad always 
step in and say ‘no participant 5, let me do it’… So I would maybe let them do it sometimes, 
and sometimes I would say, I want to try it this time… And then they would let me try it”. 
[Participant 5, P5: L124] 
 
ii. Practical problems 
 
Regarding the MDI, practical problems such as finding a private place to inject oneself and 
the awkwardness of carrying the injections around, was mentioned by most participants: 
 
“I could always do injections whenever I wanted but it wasn’t really always accessible. If 
you’re out you can’t just be fiddling about with your trousers and doing an injection if you’re 
out with your friends”. 
[Participant 6, P15, L260] 
 
 
“I don’t think you can forget the injections, you’ve got to carry them about with you. You’ve 
got to carry a pump as well but the pump goes in your pocket, the injections stick out your 
pocket”. 
[Participant 2, P11, L202] 
 
We must also not overlook the inconvenient factors associated with the insulin pump, which 
were explicitly mentioned by nearly all of the participants. These included the consequences 
of the insulin pump tubing getting caught and/or falling and the inconvenience of tucking the 
tubing in: 
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“The worst thing is when you’re running up the stairs and getting the cable or tubing caught 
on the door handle or something. I’ve done that…three times… it comes back out of you and 
it’s painful. I’ve done that once coming up the stairs, once on the bathroom door handle and 
once when I was playing sport
3... I went up for the ball and pulled it with my pinky”. 
[Participant 2, P10: L188] 
 
“Yeah sometimes, sometimes it just falls out my pocket and pulls. It’s quite sore… It doesn’t 
happen often though”. 
[Participant 7, P10: L300] 
 
 
Some participants also commented that the insulin pump can come loose when exercising, 
which can be both irritating and embarrassing: 
 
“The only thing I don’t like about it is if you’re on a trampoline and like running and you 
can, it does like move up and down. That’s a bit annoying, sometimes it’s unclipped and I’ve 
not realised, and its dangling and you are just like what, and people tell you and it’s so 
embarrassing”. 
[Participant 6, P13: L234] 
 
Yet, it seems despite these inconvenient factors, participants appear to prefer the insulin 
pump over the MDI due to the ease of use, increase in independence and the low frequency of 
the insulin pump tubing getting caught. 
 
 
iii. Visibility 
 
This sub-theme reflects how aware some of the participants were of the size and shape of 
their insulin pump. There was a split between participants’ viewpoints; some participants 
were unaffected about the visibility of their pump, whereas others were concerned about this 
and said they felt embarrassed and annoyed. Participants did not comment on the visibility of 
their MDI. 
                                                 
3
 Wording altered to prevent identification of participants. 
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Visibility: not bothered  
 
“No I don’t really bother about it… I don’t know, I’m just used to it”. 
[Participant 7, P9: L278] 
 
“Um, no I don’t really mind people seeing my pump... No, normally when I am just wearing a 
dress I just stick it under my pants or something”. 
[Participant 8, P6:L134] 
 
 
Visibility: unhappy  
 
“I hate wearing, em, I hate people noticing it cause everybody notices it. Even people who 
don’t even know me ask what it is. It annoys me cause I hate having to, cause I walk through 
school and stuff and they stare at me like, they stare, they don’t look away. I can feel they are 
staring, I can tell they are staring at me. So I just try, sometimes I’ve been in the lunch queue 
and I just try to hide it, just standing in line with someone so they don’t see it. Sometimes my 
friends lend me their cardigans cause I’ve just forgotten to bring one and then I’m like no I 
can’t, I don’t want people to see this”. 
[Participant 6, P12: L204] 
 
 
SUPER-ORDINATE THEME 5: ‘PEER REACTIONS’ 
 
This theme addresses the reactions that the participants experienced from their peers in 
relation to their insulin pumps. The majority of participants alluded to this theme during their 
interview and both positive and negative reactions were reported. It is noteworthy that none 
of the participants described their peer’s reactions to their MDI. 
 
i. Positive reactions  
“Well, like my close friends, like, like, the ones I’ve known for a long time, they know that I 
have a pump and all that, and they know a little bit about diabetes, but probably not as much 
as you know, as some people would… But, em, they are fine with it”. 
[Participant 3, P9: L198] 
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ii. Negative reactions  
“..there were times when I wish that nobody knew because at the end of last year, em, this 
really horrible boy in the other class, em stuffed paper towels down his trousers and 
pretended that it was my pump”. 
[Participant 1, P7: L164] 
 
“When I’m at clubs they always pull up my t-shirt and they say what’s that and I don’t really 
like it, and they always say that…”. 
[Participant 4, P8: L182] 
 
 
SUPER-ORDINATE THEME 6: ‘PARENTAL SUPPORT’ 
Within the interviews, parental support emerged as a significant theme in shaping 
participants’ ability to maintain a good QoL. It appeared that whilst on MDI, participants 
described being a burden to their supportive parents: 
 
Parental burden 
“Yeah, I would like, my mum would have to hold me down if my dad did it… Like I’d have to 
be held down…and sometimes I had to be held down even when my mum was doing it”. 
[Participant 1, P3: L74] 
 
“Well since my mum, when I had diabetes, when I got it, she, before she was in work4, but 
because I had diabetes she couldn’t go to work because she had to look after me. But she said 
she would rather look after you than go to work 
4”. 
[Participant 4, P2: L34] 
 
 
Yet, when speaking about the insulin pump, this burden was not reported; participants 
appeared able to simply accept parental input as positive support. 
 
 
 
                                                 
4
 Wording altered to prevent identification of participants 
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Parental support 
“It does yeah, cause now I feel that I’ve got more support and I realise that support is good 
cause I’m not always in a bad mood…. I can let them support me”. 
[Participant 2, P8: L152] 
 
In addition, multiple participants revealed that they now argued less about diabetes with their 
parents since the insulin pump: 
“Well actually there are more arguments but fewer about diabetes”. 
[Participant 1, P15: L382] 
 
 
Discussion 
 
This study is an exploration of the impact that Insulin Pump Therapy can have on young 
peoples’ QoL. The results convey an overarching message that participants’ QoL had 
changed for the better since commencing Insulin Pump Therapy. Six super-ordinate themes 
were identified: ‘Physical Impact’, ‘Mood and Behaviour’, ‘Lifestyle Flexibility’, 
‘Practicalities’, ‘Peer Reactions’, and ‘Parental Support’. Taken together, the final themes 
inform us of the complexity of the individuals’ experiences and the impact that the insulin 
pump has had on many aspects of their lives. These themes suggest a framework for 
clinicians to conceptualise how young people with T1D perceive their treatment regimes; 
recognising the more positive aspects of Insulin Pump Therapy, but taking care not to 
overlook the downsides of this treatment. Furthermore, it should be recognised that the 
themes do not stand alone, but interact with one another, as indicated in Barnard and 
Skinner’s (2007) findings.  
 
Similar to previous studies (e.g. Weintrob et al., 2003; Litton et al., 2002; Bruttomesso et al, 
2008), the first theme suggests that Insulin Pump Therapy has a positive influence on 
glycaemic control for young people. This was perceived to be a QoL benefit in both the short 
and long-term, as research indicates that better glycaemic control means fewer complications 
associated with T1D (SIGN, 2010). This was also evident throughout some of the other 
themes, which revealed that an improvement in glycaemic control has a positive influence on 
participants’ mood, behaviour and flexibility of their lifestyle.  
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Consequently, by improving glycaemic control through the use of insulin pumps, 
improvements in young peoples’ QoL can be facilitated in the short and long-term. This 
acknowledgment is of great importance as it underpins the provision of insulin pumps in the 
UK, providing further support for the Scottish Government’s initiative to fund optimal T1D 
treatment delivery (Scottish Government, 2012). In addition, these findings concur with the 
national guidelines in reporting the success of Insulin Pump Therapy within this age group 
(SIGN, 2010; NICE, 2008).  
 
Super-ordinate theme one can be further explored in relation to the impact that the different 
treatment regimes had on participants’ bodies. Participants revealed that in the past, when on 
MDI, they experienced a great deal of pain and discomfort and were often left with visible 
bruising and scars. In contrast, participants reported less pain when using the insulin pump. 
Furthermore, any scarring or bruising was reported to be easier to hide as it was situated on 
areas that are normally clothed. This appears to have had a significant impact upon young 
people’s self-image and ability to cope with their diabetes, factors which are seen to promote 
an optimal QoL. This concurs with past research by Weintrob and colleagues (2003) whom 
also indicated that the decrease in pain levels was associated with improved QoL amongst 
children. Nevertheless, we should not overlook the fact that multiple participants disclosed 
that although the insulin pump was not as painful as MDI, it caused its own physical 
difficulties. The majority of these difficulties focussed on the cannula insertion, despite the 
use of Lidocaine Hydrochloride cream to numb the area. Hence, improvements to the process 
of cannula changes could be addressed by the manufacturers in order to reduce this particular 
downside. 
 
The dominant mediating factor on the young peoples’ mood and behaviour seems to be the 
decrease in frequency of injections (super-ordinate theme two). Several participants stated 
that the decrease from an average of fifteen injections over three days, to one cannula change 
in three days, made them feel more ‘normal’ and improved their mood. Thus the reported 
difficulties of cannula insertion appear to be tempered by the apparent benefits to their mood 
and behaviour and associated QoL. Furthermore, participants commented that their glycaemic 
control improved on Insulin Pump Therapy, which had a knock-on, positive impact upon 
their mood. This finding is in line with a meta-analytical review by Lustman and colleagues 
(2000) who revealed that depression is associated with hyperglycaemia. 
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Recent research suggests that lifestyle flexibility is a major influencing factor on the QoL of 
people with T1D (Todres et al., 2010). These findings were supported by this study which 
identified that young people reported a positive improvement in the flexibility of their 
lifestyle as a consequence of starting Insulin Pump Therapy (super-ordinate theme three). In 
accordance with past research, such as Hoogma and colleagues (2005), participants indicated 
an improvement in the flexibility of their eating, exercise, social life, sleep and daily routines. 
Furthermore, when describing these changes, they seemed noticeably more animated; 
possibly indicating lifestyle flexibility makes the biggest difference to their QoL. 
 
An interesting theme to arise from these data was the day-to-day practicalities of the 
treatment regime (super-ordinate theme four).  Specifically, the insulin pump was reported to 
be more convenient and easier to use than MDI. This can be attributed to the insulin pump 
allowing for greater technical control and ease of learning. However, it must also be 
considered that this may be attributable to participants increase in age and the fact that they 
have had more time to adjust to having diabetes. Nevertheless, nearly all the participants were 
in agreement that the insulin pump was more convenient, but this came with caveats.  
 
Some participants reported that, occasionally, the insulin pump tubing could get caught, 
resulting in the cannula falling out and/or the pump falling to the floor. Furthermore, some 
participants described issues when they were exercising and the pump moving. Whereas, 
practical concerns regarding the MDI was captured by reports of the awkwardness of 
carrying the injections and issues regarding privacy when having to inject oneself.  
 
The MDI concerns have been recognised in past research (E.g. Peyrot et al., 2010), however, 
the insulin pump concerns have not fully been explored, except for by Barnard and Skinner 
(2007) who highlighted a few technical issues such as “when things go wrong”. The question 
therefore arises; are these insulin pump concerns more relevant to young people? One 
tentative hypothesis may be that young people tend to engage in more risk taking behaviours 
which have the potential to cause things to go amiss, such as with their insulin pumps 
(Jackson et al., 2010; Suris et al., 2008). Furthermore, the young people interviewed traverse 
a range of developmental stages which can impact upon their self-esteem levels. For 
example, some of the participants were at an age when they are more aware of others 
judgements and so may find situations where they feel embarrassed to be highly aversive 
(Robins et al., 2002). Alternatively, it is possible that this factor has not been found in adult 
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literature due to the dearth of qualitative studies which would permit wider exploration of 
patients’ experiences. These tentative hypotheses require further examination in order to fully 
understand the limitations of the insulin pumps within a younger age group.  
 
Similar to Barnard and Skinner’s (2007) study, some of the young people reported visibility 
of the insulin pump to be a key weakness of this treatment regime. However, others did not 
seem to mind that it could be easily seen (continuation of super-ordinate theme four). 
Additionally, participants also described peers’ reaction to their insulin pump, which suggests 
that there are two opposing camps (super-ordinate theme five). On one side you have young 
people who have encountered negative reactions from their peers, which in turn appears to 
make them feel embarrassed and annoyed. In contrast, we have the alternative view, where 
participants reported positive reactions from their peers and felt ‘fine’. This leads us to 
question, what is the difference between those who mind and those who don’t and those who 
experience negative reactions from peers and those who don’t? The characteristics of our 
participants do not appear to give us any clue and so this leads one to wonder what the 
underlying mechanisms are. Unfortunately, this study is currently unable to answer this 
question, but it may prove useful to bear in mind for future research and when working 
clinically with young people.  
 
In the final super-ordinate theme, participants described feeling they were a burden to their 
parents when on MDI, whereas now on their insulin pump, they revealed that they are able to 
accept this as positive support. This is an interesting concept and one which appears to be 
partially unique to this study. Barnard and Skinner (2007) revealed that participants felt they 
now had greater independence for both themselves and for their family members, which is 
reflected in these findings. This theme, however, goes one step further and looks at the 
impact not only on their independence, but also on young people’s perception of their illness 
as a ‘burden’ or ‘normal’. This increased sense of normalisation suggests a positive impact on 
young people’s QoL. It is also of interest to note that some parents commented in passing to 
the researchers that they found transitioning to Insulin Pump Therapy a greater burden. 
Hence, it would be interesting to conduct a follow-up study investigating parental attitudes 
and beliefs towards Insulin Pump Therapy. 
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Strengths and Limitations 
There are a multitude of strengths within this study, which add validity to the findings, such 
as the homogeneity in the sample and the fact that the participants were interviewed 
individually. The gender balance was 75% female; 25% male which reflected the overall 
gender balance of young people on insulin pumps within this regional hospital (Lamb, 2012). 
Furthermore, the ease of recruitment reflects the salience of this topic to the participants. 
Nevertheless, limitations must be recognised. 
 
One such shortcoming is that only three children were interviewed resulting in a mix of 
developmental stages which may have confounded the results. In addition, it is not known if 
age and/or duration at commencement of Insulin Pump Therapy, and/or the number of 
injections per day prior to Insulin Pump Therapy may have affected participants’ answers. 
However, McMahon and colleagues (2005) conducted a large scale quantitative study and 
reported no significant impact of these factors on glycaemic control or QoL measures. It 
should also be noted that the inclusion criteria specifically stated that participants must have 
been on Insulin Pump Therapy for a minimum of six months. This was to allow for any 
novelty effect of a new treatment to wear off and for most patients to be established on 
Insulin Pump Therapy. Further, young people with co-morbid medical conditions were 
excluded from this study to prevent cross-contamination of the results. Hence, these 
parameters may impact the generalisability of the results for those young people who have 
just initiated Insulin Pump Therapy and/or suffer with an additional medical condition.  
 
Implications for clinical practise 
The findings from this study provide some unique insights into the personal experiences of 
young people with T1D. It is from this that we can extrapolate and consider both the clinical 
implications and recommendations for healthcare professionals involved in their care. The 
expectations of young people preparing to start Insulin Pump Therapy need to be addressed, 
with professionals providing clear and concise information about the benefits, but also the 
potential problems with this treatment. The present service currently offers this information 
to young people via contact with a dedicated Clinical Psychologist and the Clinical Nurse 
Specialist, but this study indicates that we need to ensure this information is also being 
conveyed to parents in order to optimise their support throughout this challenging time. 
Greater understanding of the concerns of this population may facilitate guidance 
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opportunities within schools and thus identify appropriate support. In addition, the provision 
of a brief group psychoeducational intervention to increase young peoples’ self-esteem prior 
to and during the commencement of Insulin Pump Therapy may be beneficial. Finally, it may 
also be of use for the insulin pump product designers to consider the potential pitfalls which 
our participants have encountered, such as the tubing getting caught and look to an alternative 
solution to minimise this risk factor. 
 
 
Implications for future research 
Perhaps one of the key strengths of this study is that it fills a gap in the research and 
highlights the remarkable value a qualitative study can provide. The richness of this data has 
conveyed important insights into the lives of young people with T1D. It has portrayed areas 
of interest which, in the past, quantitative studies have only been able to allude to and 
tentatively hypothesise about. Further studies are needed to focus more on the generalisability 
of these QoL benefits among different population groups, including those with co-morbidities 
and in terms of long-term usage, as the longest duration of insulin pump use in this study was 
only two and a half years. It would also be beneficial to conduct further research, which 
focuses on how to reduce the impact of the reported downsides to Insulin Pump Therapy. 
Lastly, qualitative research exploring the wider impact of Insulin Pump Therapy from a 
parent perspective would be particularly worthwhile. 
 
 
Conclusions 
Improvements in QoL mean different things to different people, but what this study suggests 
is that there is a general agreement amongst the sample of young people interviewed that 
switching to Insulin Pump Therapy has resulted in improvements to their QoL. This study 
reflects the participants’ enthusiasm for Insulin Pump Therapy, while simultaneously 
recognising the potential problems of this treatment regime.  
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Abstract 
 
Reflective practice aims to facilitate Clinical Psychologists to engage in continuous learning 
by reflecting on their own work.  This can be considered of vital importance for both 
professional and self-development.  This critical reflective account describes my experiences 
of working within a multi-disciplinary team, and the limitations and roles which this entails.  
It is structured around Gibb’s (1988) reflective model to analyse my thoughts, feelings and 
behaviours that occurred in response to two specific experiences of Multidisciplinary Team 
(MDT) working which highlighted my changing role, and my exploration of specific issues 
such as resistance, and limitations within a team.  I also draw upon the National Occupational 
Standards for Psychology (BPS, 2006), the Code of Ethics and Conduct (BPS, 2009) and the 
policy New Ways of Working for Applied Psychologists (BPS, 2007) to guide my thoughts, 
and reflect on these experiences in the wider context.  I draw on two specific examples, firstly 
one which illustrates the change in my skills and confidence over the past three years at MDT 
meetings, with particular emphasis on my changing role within these meetings.  Secondly, I 
demonstrate the importance of knowing my own limitations within a MDT, and being able to 
communicate this to my colleagues effectively.  The learning experiences from these 
reflections are discussed, and my enhanced awareness of the evolving role of a Clinical 
Psychologist is reflected upon. 
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Abstract 
 
 
Reflective practice and Clinical Psychology are synonymous terms, as it is through the 
process of critical reflection that a clinician’s learning and subsequent continuous 
professional development is facilitated. In this account, I have reflected on how the role I 
have fulfilled in my placements has largely been determined by the specific skills set required 
by the service itself. The reflections contained in this account are based on the experiences I 
accrued in my current placement within adult health (Oncology and Cardiology) and in my 
first year placement in a Primary Care Mental Health (PCMH) team. This account is broadly 
structured around Johns and Graham’s (1996) five-stage model to support reflections on four 
primary themes which relate to how the individuality of services impacted upon my role: 1) 
multidisciplinary team requirements, 2) local and national policies, 3) crisis management, and 
4) supervision needs. This account has encouraged me to reflect upon my experiences 
throughout training and consider how I will use these reflections in my future life as a 
qualified Clinical Psychologist.  
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Appendix 1.1 – Author Publication Guidelines 
British Journal of Heath Psychology 
The aim of the British Journal of Health Psychology is to provide a forum for high quality research 
relating to health and illness. The scope of the journal includes all areas of health psychology across 
the life span, ranging from experimental and clinical research on aetiology and the management of 
acute and chronic illness, responses to ill-health, screening and medical procedures, to research on 
health behaviour and psychological aspects of prevention. Research carried out at the individual, 
group and community levels is welcome, and submissions concerning clinical applications and 
interventions are particularly encouraged.  
The types of paper invited are:  
• papers reporting original empirical investigations;  
• theoretical papers which may be analyses or commentaries on established theories in health 
psychology, or presentations of theoretical innovations;  
• review papers, which should aim to provide systematic overviews, evaluations and interpretations 
of research in a given field of health psychology; and  
• methodological papers dealing with methodological issues of particular relevance to health 
psychology.  
1. Circulation  
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world.  
2. Length  
Papers should normally be no more than 5000 words (excluding the abstract, reference list, tables 
and figures), although the Editor retains discretion to publish papers beyond this length in cases 
where the clear and concise expression of the scientific content requires greater length.  
3. Editorial policy  
The Journal receives a large volume of papers to review each year, and in order to make the process 
as efficient as possible for authors and editors alike, all papers are initially examined by the Editors 
to ascertain whether the article is suitable for full peer review. In order to qualify for full review, 
papers must meet the following criteria:  
• the content of the paper falls within the scope of the Journal  
• the methods and/or sample size are appropriate for the questions being addressed  
• research with student populations is appropriately justified  
• the word count is within the stated limit for the Journal (i.e. 5000 words)  
For full details see: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2044-
8287/homepage/ForAuthors.html 
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Appendix 1.2: Quality Assessment Tool 
The impact of Parenting style on young people’s adherence to their diabetes self-
management treatment regime and glycaemic control: A systematic review 
Authors  
Title of Article  
Title of Journal   
Date of publication  
Completed by  
Completed on  
 
1. INTERNAL VALIDITY 
1.1 Does the study have a clear aim and hypothesis? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
2. INTRODUCTION 
2.1  Has the scientific background and explanation of 
rationale been provided? 
 
 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
3. METHOD 
3.1 Is the population and how it is recruited is clearly stated? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
3.2 Are details provided of participant characteristics and 
are they representative of the target group (e.g. gender, 
age, ethnicity, socio-economic status, disease duration)? 
2 Well covered and representative 
sample 
1 Adequately covered but 
unrepresentative of the target group 
0 Poorly/not covered 
3.3 Is the inclusion and exclusion criteria clearly stated? 2 Well covered 
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1 Adequately covered 
0 Poorly/not covered 
3.4 Was a power calculation used? 1 Yes 
0 No 
3.5 Does the article outline the flow of participant’s through 
each stage? 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
4. ASSESSMENT 
 
4.1 
Were the outcome measures clearly defined? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
4.2 Is adherence to diabetes treatment regime measured 
appropriately? E.g. HbA1c and validated questionnaire 
 
 
3 Observational and self-report 
methods 
 
2 Observational or Standardised 
self report measure – good validity 
 
1 Standardised self-report measure 
– poor/unknown validity 
 
0 Non-standardised tools 
4.3 Is parenting style measured appropriately? 
 
3 Observational and self-report 
methods 
 
2 Observational or Standardised 
self report measure – good validity 
 
1 Standardised self-report measure 
– poor/unknown validity 
 
0 Non-standardised tools 
5. CONFOUNDING VARIABLES 
5.1 Are the main potential confounders identified and taken 
into account in the design and analysis? 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
 
6. STATISTICAL ANALYSIS 
6.1 Is the analysis conducted appropriate to the design? 1 Yes 
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0 No 
6.3 Are the results clearly reported? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
6.4 Are confidence intervals, effect sizes, p-values etc. 
provided where appropriate? 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
 
7. DISCUSSION 
7.1 Are the limitations of the research study described? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
7.2 Is the generalizability of the research discussed? 2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
7.3 Do the authors provide recommendations for clinical 
practice or future research in relation to the findings? 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
7.4 Do the conclusions drawn directly link to the results 
achieved? 
2 Well covered 
1 Adequately covered 
0 Poorly/not covered 
Total Score (out of 36): 
Percentage (%): 
Overall Quality Rating:  
 
*Overall Quality Rating Key 
(80% + Good) 
(55-79%Moderate) 
(<54% Poor) 
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Appendix 1.3: Quality rating of studies included in systematic review 
 
Study Quality Score 
(max = 36) 
Percentage 
Quality Rating  
Descriptive 
Quality Rating 
Shorer et al., 
2011 
20 55.6% Acceptable 
Armstrong et 
al., 2011 
31 86.1% Good 
Greene et al., 
2010 
32 88.8% Good 
Jaser and Grey, 
2010 
27 75% Acceptable 
Sherifali et al., 
2009 
28 77.8% Acceptable 
Duke et al., 
2008 
30 83.3% Good 
Faulkner and 
Chang, 2007 
28 77.8% Acceptable 
Butler et al., 
2007 
27 75% Acceptable 
Lewin et al., 
2006 
31 86.1% Good 
Davis et al., 
2001 
29 80.6% Good 
 
(A) representing a percentage score of 80% (good quality)  
(B) representing a percentage score of 55-79% (acceptable quality)  
(C) representing a percentage score of 0-54% (poor quality) 
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Appendix 1.4:  Psychometric Values of Measures 
 
 
 
Adherence Measure 
 
Reference 
 
Psychometric Values  
(Internal consistency) 
Adherence to Diabetes 
Treatment Regimen 
Questionnaire 
Tom-Katzav, 2007 Not stated 
The Self-Care Inventory 
(Child and Parent Version) 
La Greca et al., 1990 0.73 – 0.84 
The Diabetes Self-Care 
instrument 
 
Greene et al., 2010 0.79 
The Pediatric Quality of Life 
Inventory 
Varni et al., 2003 0.84 
Diabetes Self-Management 
Profile 
Harris et al., 2000 0.65 – 0.86 
Self-Care Questionnaire 
 
Saucier and Clark, 1993 0.78 
 
 
Parenting Measures 
 
Reference 
 
Psychometric Values  
(Internal consistency) 
Parental Authority 
Questionnaire 
Buri, 1991 Not stated 
Diabetes Family Behaviour 
Checklist 
Schafer et al., 1986 0.60 – 0.82. 
62-item Parenting Practices 
report 
Robinson et al., 1995 0.75 – 0.91 
The Iowa Family Interaction 
Rating Scale 
Melby and Conger, 2001 0.61 – 0.79 
The Parenting Dimension 
Inventory 
Power, 1993 0.55 – 0.85 
Diabetes Family Behaviour 
Scale 
Waller et al., 1986 0.69 – 0.83 
Child/Parent Report of 
Parent Behaviour Inventory 
Schaefer, 1965a/1965b 0.81 – 0.90 
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Appendix 2.1 – Author Publication Guidelines 
British Journal of Heath Psychology 
 
The aim of the British Journal of Health Psychology is to provide a forum for high quality 
research relating to health and illness. The scope of the journal includes all areas of health 
psychology across the life span, ranging from experimental and clinical research on 
aetiology and the management of acute and chronic illness, responses to ill-health, 
screening and medical procedures, to research on health behaviour and psychological 
aspects of prevention. Research carried out at the individual, group and community levels is 
welcome, and submissions concerning clinical applications and interventions are particularly 
encouraged.  
 
The types of paper invited are:  
• papers reporting original empirical investigations;  
• theoretical papers which may be analyses or commentaries on established theories in 
health psychology, or presentations of theoretical innovations;  
• review papers, which should aim to provide systematic overviews, evaluations and 
interpretations of research in a given field of health psychology; and  
• methodological papers dealing with methodological issues of particular relevance to 
health psychology.  
 
1. Circulation  
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world.  
 
2. Length  
Papers should normally be no more than 5000 words (excluding the abstract, reference list, 
tables and figures), although the Editor retains discretion to publish papers beyond this 
length in cases where the clear and concise expression of the scientific content requires 
greater length.  
 
3. Editorial policy  
The Journal receives a large volume of papers to review each year, and in order to make the 
process as efficient as possible for authors and editors alike, all papers are initially examined 
by the Editors to ascertain whether the article is suitable for full peer review. In order to 
qualify for full review, papers must meet the following criteria:  
• the content of the paper falls within the scope of the Journal  
• the methods and/or sample size are appropriate for the questions being addressed  
• research with student populations is appropriately justified  
• the word count is within the stated limit for the Journal (i.e. 5000 words)  
 
For full details see: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2044-
8287/homepage/ForAuthors.html 
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 Appendix 2.2. Ethics Approval Letters 
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Appendix 2.3 – Hospital criteria to determine eligibility for Insulin Pump Therapy 
Children’s Diabetes Service  
Insulin Pump Pathway 
 
Planning Pump Therapy 
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Appendix 2.4 – Information Pack 
 
University of Glasgow        
Department of Mental Health and Wellbeing 
Gartnavel Royal Hospital 
Administration Building 
1055 Great Western Road 
Glasgow, G12 0XH 
 
 
Participant Information Sheet: 8 > 12 years olds 
 
 
Title: The effects of insulin pump therapy on young people’s quality of life 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what you would need to do. Please take time 
to read this information and talk to your parent/guardian about it.   
 
Who is carrying out the research?  
The research is being carried out by Jennifer Whittaker and Dr Sarah Wilson from Glasgow 
University’s Academic Unit for Mental Health and Well Being, alongside Dr Liz Hunter 
from the Department of Clinical Psychology at Yorkhill.  
 
Why are we doing this study?  
We want to know what effect using an insulin pump has on the lives of the young people who 
use them. We are hoping that with this information, we will be able to help the hospital to 
improve their service to young people like you and make using an insulin pump easier for 
both you and other children.  
 
Why have I been invited to take part?  
All young people who have changed from injections to insulin pump therapy over the past 
three years; attend the diabetes clinic; and are aged 8 – 15 years old have been invited to take 
part in this study.   
 
Do I have to take part?  
No – it is up to you and your parent/guardian to decide. If you do decide to take part, you will 
be given a copy of this information sheet to keep and be asked to sign a form to show you 
have agreed to take part. Your parent/guardian will also be asked to do this. You are free to 
stop at any time and without giving a reason. This will not affect your care or treatment. 
 
What will happen if you take part? 
You will meet with Jennifer for about 30 - 45minutes to talk about the effect that insulin 
pump therapy has had on your life. This will be recorded, and will be kept completely 
private. The recordings will be destroyed once we have taken the information from them.  
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What happens to the information?  
The recordings will be typed up with all personal information such as your name removed. 
This will be kept on a safe computer, and then the recordings will be destroyed. We will not 
share this information with other people, without you, and your parent/guardians permission. 
We may use  information you have given us in writing a report on this study but we will 
make sure that  no one can  tell who gave it to us. 
 
What are the possible risks of taking part? 
There are no direct risks from taking part, although some people may feel uncomfortable 
talking about their experiences. If we are worried then we would ask you if you would like 
extra help from the Diabetes Team. This would be discussed with you and your 
parent/guardian. You could also choose to speak with someone from the psychology service 
attached to the Diabetes Clinic. 
 
Who has reviewed the study?  
This study has been reviewed by NHS West of Scotland Research Ethics Committee 2. 
 
If you are interested in taking part? 
If you would like to take part, please ask your parent/guardian to complete the tear-off slip on 
their information sheet and return it in the envelope provided (no stamp required), or to pass 
this on to a member of the diabetes team. 
 
Or, please ask them to contact Jennifer Whittaker or Sarah Wilson on 0141 211 3921. 
 
If you would like some more information about the study, please do not hesitate to contact us. 
Or, if you would prefer to talk to someone not involved in the research, please contact Dr 
Ken Mullen Lecturer, School of Medicine University of Glasgow, on 0141 211 3932. 
 
 
 
Thank You for Reading this Information Sheet 
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University of Glasgow 
Department of Mental Health and Wellbeing 
Gartnavel Royal Hospital 
Administration Building 
1055 Great Western Road 
Glasgow, G12 0XH 
 
 
Participant Information Sheet: 12 > 16 years olds 
 
 
Study Title: The effects of insulin pump therapy on young people’s quality of life 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully and discuss it with your parent/guardian.  
Ask us if there is anything that is not clear or if you would like more information. 
 
Who is conducting the research?  
The research is being conducted by Jennifer Whittaker and Dr Sarah Wilson from Glasgow 
University’s Academic Unit for Mental Health and Well Being, alongside Dr Liz Hunter 
from the Medical Paediatric Department of Clinical Psychology. This research is part of the 
Doctorate in Clinical Psychology qualification. 
 
Why are we doing this study?  
We want to know what effect using an insulin pump has on the lives of the young people who 
use them. We are hoping that with this information, we will be able to help the hospital to 
improve their service to young people like you and make using an insulin pump easier for 
both you and other children.  
 
Why have I been invited to take part?  
All young people who have changed from multiple daily injections to insulin pump therapy 
over the past three years, attend the diabetes clinic, and are aged 8 – 15 years old have been 
invited to take part in this study.   
 
Do I have to take part?  
No – it is up to you and your parent/guardian to decide. If you do decide to take part, you will 
be given a copy of this information sheet to keep and be asked to sign a consent form to show 
you have agreed to take part. Your parent/guardian will also be asked to read an information 
sheet and sign a consent form. You are still free to stop at any time and without giving a 
reason. A decision to stop, or a decision not to take part, will not affect the care that you 
receive or any future treatment. 
 
What will happen if you take part? 
The research involves meeting you to talk about the effect that insulin pump therapy has had 
on your life. Taking part will take about 30-45 minutes and will be recorded. The recording 
will only be used for this research study, and all the information will be kept  
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completely private, and then the recordings will be destroyed once we have taken the 
information from them.  
 
What happens to the information?  
Your personal information will be kept completely private and known only to the researchers. 
The recordings will be typed up with all personal information removed. These typed records 
will be kept on a secure computer, and then the recordings will be destroyed. We will not 
share this information with other people, without you, and your parent/guardians permission. 
 
What are the possible risks of taking part? 
There are no direct risks from taking part, although some people may feel uncomfortable 
talking about their experiences. If we are worried about your wellbeing, we would ask you if 
you want the Diabetes team to offer some extra help. This would be discussed with you and 
your parent/guardian and the option of being referred to the dedicated psychology service 
attached to the Diabetes clinic would be available. 
 
Who has reviewed the study?  
This study has been reviewed by NHS West of Scotland Research Ethics Committee 2. 
 
If you are interested in taking part? 
If you would like to take part, please ask your parent/guardian to complete the tear-off slip on 
their information sheet and return it in the envelope provided (no stamp required), or to pass 
this on to a member of the diabetes team. 
Alternatively, please ask them to contact Jennifer Whittaker or Sarah Wilson on 0141 211 
3921. 
 
If you would like some further information about the study, please do not hesitate to contact 
us. Alternatively, if you would prefer to talk to an independent person, out-with the research 
team, please contact Dr Ken Mullen Lecturer, School of Medicine University of Glasgow, on 
0141 211 3932. 
 
 
 
Thank You for Reading this Information Sheet 
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University of Glasgow 
Department of Mental Health and Wellbeing 
Gartnavel Royal Hospital 
Administration Building 
1055 Great Western Road 
Glasgow, G12 0XH 
 
 
Parent/Guardian Information Sheet 
 
 
Study Title: The effects of insulin pump therapy on children's quality of life 
We would like to invite your child to take part in a research study. Before you decide you 
need to understand why the research is being done and what it would involve for them. Please 
take time to read the following information carefully. Talk to others about the study if you 
wish. Ask us if there is anything that is not clear or if you would like more information. 
 
Who is conducting the research?  
The research is being conducted by Jennifer Whittaker and Dr Sarah Wilson from Glasgow 
University’s Academic Unit for Mental Health and Well-being alongside Dr Liz Hunter from 
the Medical Paediatric Department of Clinical Psychology. 
 
What is the purpose of this study?  
We want to find out what effect insulin pump therapy has on children’s quality of life. This 
information will help the hospital services by identifying the types of support that are 
required to make the use of insulin pumps as successful as possible for every child that uses 
one. 
 
Why has my child been invited to take part?  
All children who have changed from multiple daily injections to insulin pump therapy over 
the past three years, attend the diabetes clinic, and are aged 8 – 15 years old have been invited 
to participate in this study.   
 
Does my child have to take part?  
Participation is completely voluntary and confidential. It is up to you and your child whether 
or not to take part. If your child does decide to take part you will be given this information 
sheet to keep and be asked to sign a consent form to show you have agreed to your child 
taking part.  Your child will also be asked to read an information sheet and sign a consent 
form.  Even if you decide that your child will take part, they are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any time, or a decision not to 
take part, will not affect the standard of care that your child receives or their future treatment. 
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What will happen if your child takes part? 
The researcher will meet with your child to talk about how using an insulin pump affects their 
life. This interview will take approximately 30-45 minutes and will be voice recorded. This 
recording will only be used for the purposes of this research, all the information will be 
completely anonymised before it is analysed, and the recordings will then be erased.  
 
What happens to the information?  
Your child’s identity and personal information will be completely confidential and known 
only to the researchers. The voice recordings will be written out word-for-word (transcribed) 
and will be anonymised during transcription.  Transcriptions will be kept on an encrypted 
computer so that only the research team will be able to access them. Once the transcription 
has been checked, the recording will be erased. The data will be held in accordance with the 
Data Protection Act, which means that we keep it safely and cannot reveal it to other people, 
without your permission. 
 
What are the possible risks of taking part? 
There are no direct risks from taking part, although some children might feel uncomfortable 
talking about their experiences. If any concerns arose about your child’s wellbeing, the 
researcher would ask your child if they would like the Diabetes team to provide extra support. 
If we felt your child was in need of psychological input, this would be discussed with both 
you and your child and the option of requesting a referral to the dedicated psychology service 
attached to the Diabetes clinic would be available. 
 
Who has reviewed the study?  
This study has been reviewed by the NHS West of Scotland Research Ethics Committee 2. 
 
If you are interested in taking part? 
If you would like to take part, please complete the tear-off slip below and return it either in 
the stamped addressed envelope provided (no stamp required), or pass this on to a member 
of the diabetes team. 
 
Alternatively, please contact Jennifer Whittaker or Sarah Wilson on 0141 211 3921. 
 
If you would like some further information about the study, please do not hesitate to contact 
us. Alternatively, if you would prefer to talk to an independent person, out-with the research 
team, please contact Dr Ken Mullen Lecturer, School of Medicine University of Glasgow, on 
0141 211 3932. 
 
 
If you have a complaint about any aspect of the study? If you are unhappy about any 
aspect of the study and wish to make a complaint, please contact the researcher in the first 
instance, but the normal NHS complaint procedure is also available to you. 
 
 
 
 
 
 
90 | P a g e  
 
Thank you for your time and co-operation. 
(Tear off Slip) 
 
 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Research Study: The effects of insulin pump therapy on children's quality of life 
Chief Investigator: Jennifer Whittaker 
Trainee Clinical Psychologist (University of Glasgow / NHS Ayrshire and Arran) 
Participant Name Signature 
Telephone 
For office use: An interpretative phenomenological analysis on the effects of continuous 
subcutaneous insulin infusion (CSII) therapy on children and adolescent’s quality of life. 
 Participant number: 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
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University of Glasgow 
Department of Mental Health and Wellbeing 
Gartnavel Royal Hospital 
Administration Building 
1055 Great Western Road 
Glasgow, G12 0XH 
 
Subject number: 
 
The effects of insulin pump therapy on young people’s quality of life 
 
Participant Consent Form  
 
Please initial the BOX 
          Please initial box 
 
I confirm that I have read and understand the information sheet dated 29/08/2011 (version 1) 
for the above study and have had the opportunity to ask questions 
 
I understand that I do not have to take part in this study. It is my choice and I can stop at any 
time, without giving a reason and that this will not affect any part of my care. 
 
I am aware that the interview will be recorded by the researcher, Jennifer 
Whittaker, and only used for the purposes of the research study, as described in the 
information sheet. 
 
I understand that all names, places and anything that could identify me will be 
removed and nothing that identifies me will appear for others to see. 
 
I agree to take part in the above study 
 
 
 
---------------------------------------               -----------------         ---------------------------------- 
Name of Participant           Date      Signature 
 
 
 
---------------------------------------               -----------------          --------------------------------- 
Name of Researcher           Date       Signature 
 
 
 
1 copy to the patient, 1 copy to the researcher, 1 Original for the patients’ notes 
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University of Glasgow 
Department of Mental Health and Wellbeing 
Gartnavel Royal Hospital 
Administration Building 
1055 Great Western Road 
Glasgow, G12 0XH 
 
Subject number: 
 
The effects of insulin pump therapy on young people’s quality of life 
 
Parent/Guardian Consent Form  
 
Please initial the BOX 
          Please initial box 
 
I confirm that I have read and understand the information sheet dated 29/08/2011 (version 1) 
for the above study and have had the opportunity to ask questions 
 
I understand that this is voluntary and my child can withdraw at any time, without giving a 
reason and that this will not affect any aspect of their care. 
 
I am aware that the interview will be recorded by the researcher, Jennifer 
Whittaker, and only used for the purposes of the research study, as described in the 
information sheet. 
 
I understand that all names, places and anything that could identify my child or me 
will be removed and nothing that identifies my child will appear for others to see. 
 
I agree to my child taking part in the above study 
 
 
 
---------------------------------------               -----------------         ---------------------------------- 
Name of Participant           Date      Parent/Guardian Signature 
 
 
 
---------------------------------------               -----------------          --------------------------------- 
Name of Researcher           Date       Signature 
 
 
 
1 copy to the patient, 1 copy to the researcher, 1 Original for the patients’ notes 
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Appendix 2.5 – Interview Schedule 
 
Interview Schedule (Version 1, 29/08/11) 
The below questions will be used as a guide only to initiate discussion. Prior to commencing 
interviews, participants will be reminded that they can have a break at any point and that 
there are no right or wrong answers. They will also be reminded that the information will be 
anonymous.  
 
A. Type 1 Diabetes  
 
Q: If you imagine you have been asked to explain type 1 diabetes to someone who knows 
nothing about it what would you say? 
Prompt:  How is it caused? What are the symptoms? How does it affect your body? 
How much control do you have over it? How does it affect you on a day-to-day basis?  
 
Q: What do you think about having Diabetes?  
Prompt: How do you feel about having Diabetes? 
 
B. Multiple Daily Injections (MDI) 
Q: What did you call it when you were taking MDIs? 
Prompt: Injections? 
 
Q: Can you remember what your MDI regime was like? 
Prompt: Number of injections, Glycaemic control – particularly in the evenings: 
HbA1c levels, Weight, Pain. 
 
Q: When on MDI, did you feel in control of your diabetes? 
 Prompt: Did you feel like you could manage your diabetes without any help? 
 
Q: Did you have any difficulties with your diabetes when you were on MDI? 
Prompt: What did the health professionals tell you? What did your parents and family 
say? What did your friends say? How did you feel? Did it cause arguments within the 
family? 
 
Q: Were there many visits to hospital when you were on MDI? 
Prompt: If you are not sure, take a guess. More variable blood sugar results? 
 
Q: Did the MDI affect your body? 
Prompt: physical side-effects? (e.g. lumpy/marked legs), Physical complaints or 
restrictions? 
 
Q: Did the MDI affect you socially?  
Prompt: Was it difficult/embarrassing to inject yourself? Did having to inject yourself 
affect your friendships/restrict your life?  
 
Q: Did the MDI have an impact on your feelings?  
Prompt: Did you worry about having to inject yourself?  
 
Q: How did you cope with your diabetes when on MDI?  
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Prompt: Did you alter your eating, exercise, sleeping habits, frequency of blood 
glucose monitoring? 
 
Q: Did you speak with anyone to help you manage your diabetes? 
Prompt: Who supported you at that time – parents, friends, diabetes nurse? 
 
Q: Can you remember how you felt when on MDI?  
Prompt: what was your mood like and was it affected by your diabetes? Were you 
confident about doing your part in controlling your diabetes? 
 
Q: Do you think that you used to cope well with the MDIs? 
Prompt: If not, what was it that was difficult for you to cope with? 
 
 
C.  Insulin Pump 
 
Q: What was your regime like now? 
Prompt: Glycaemic control – particularly in the evenings: HbA1c levels, Weight, 
Pain. 
 
Q: Do you feel more in control of your diabetes now you are on an insulin pump? 
Prompt: Do you feel like you could manage your diabetes independently? 
 
Q: Is the insulin pump causing any difficulties with your diabetes? 
Prompt: What do the health professionals tell you? What do your parents and family 
say? What do your friends say? How do you feel? Does it cause arguments within the 
family? 
 
Q: Do you go to hospital more or less since you have been on the insulin pump? 
Prompt: If you are not sure, take a guess. More variable blood sugar results?  
 
Q: What effect does the insulin pump have on your body? 
 Prompt: side-effects? Physical complaints or restrictions? 
 
Q: What effect does the insulin pump have on you socially? 
Prompt: Is it difficult/embarrassing to have an external device on yourself – does this 
restrict your lifestyle? 
 
Q: What effect does the insulin pump have on you emotionally? 
Prompt: Did you worry about your diabetes more than you used too? 
 
Q: Do you have to change things in order to cope with having diabetes now you are on an 
insulin pump? 
Prompt: Do you alter your eating, exercise, sleeping habits, frequency of blood 
glucose monitoring? 
 
Q: Do you speak with anyone to help you manage it? 
Prompt: Who supports you? – parents, friends, diabetes nurse. 
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Q: How are you feeling now?  
Prompt: what is your mood like and is it affected by your diabetes? Are you more 
confident about doing your part in controlling your diabetes? 
 
Q: Do you think that you cope well, being on the insulin pump? 
Prompt: Can you tell me more about that? 
 
 
D. Overall 
Q: Which treatment made you feel more in control of your diabetes? 
Prompt: Insulin pump or MDI? Can you tell me more about that? 
 
Q: What differences has being on an insulin pump made to your family? 
Prompt: More independence? Control? Fewer arguments? 
 
Q: Have your feelings towards your diabetes changed since starting on the insulin pump? 
Prompt: Can you tell me more about that? 
 
Q: Has the insulin pump had any impact on your life? 
Prompt: has it changed your future? 
 
Q: What is the best and worst thing about insulin pump versus MDI? 
Prompt: Can you tell me more about that? 
 
Q: Are you going to stay on insulin pump long-term? 
Prompt: Yes, Maybe, No. 
 
Q: Would you recommend the insulin pump over MDI to other children your age? 
 Prompt: Yes, Maybe, No.  
 
Q: What advice would you give to someone who is going to start insulin pump now? 
 Prompt: Can you tell me more about that? 
 
Q: Is there anything else you would like to tell me? 
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Appendix 2.6 – Transcript and Coding Example (P6, pp 7- 8) 
 
I = Interviewer 
P = Participant 
 
 
 Interview Notes/Codes 
I Very good, so when you were on the injections, what 
was your control, what was your control of your blood 
sugars like? Was it ok or? 
 
P They were really, really, I think they were really good, 
I think I got it down to 7.  
Glycaemic control good on 
jags 
I Wow  
P With my injections, 6.9, I don’t know whether that 
was on the pump on not. It was really good control, 
and em, its really easy now if I do, If there is 
something wrong with my Cannula, I like at school, I 
can still get my pump, type it in, and it tells me and I 
just type that into the injections and I know exactly 
what to give, I don’t have to work it out on paper or 
anything. 
Glycaemic control good on 
jags 
 
Pump easier to use  
 
Cannula problems 
 
Pump more automatic – 
helps to work out amounts of 
insulin required. 
I Oh that’s really good so the pumps, been quite 
advantageous in that way cause it tells you exactly 
what you need to do and its less work in a way. 
 
P Well there has been, there is a thing. My tube got 
caught on a bag and the person kept walking and they 
didn’t realise and it snapped. 
Tubing getting caught 
I Oh my goodness.  
P And they didn’t realise it was half snapped, and I was 
just walking along and it was really embarrassing but 
yeah it was like really, you couldn’t use it, and it was 
about to be lunch so I just typed it in and I had to do 
injections that day but I didn’t feel them and it was 
fine. 
Tubing getting caught – 
embarrassment 
 
Pump not working so having 
to rely on injections 
I Ok, so you said that it kinda, it got caught cause some 
people have said that because the tube falls out of your 
pocket or comes out of wherever you’ve put it, cause 
it can be quite long at times that it can actually get 
caught quite easily. Has that happened a lot or is it just 
the once? 
 
P Em, its got caught a few times, um, it sometimes gets 
caught, I think it once got caught on a desk, but 
nothing happened like it wasn’t damaged badly. It got 
caught on the side of the desk and I remember walking 
and getting pulled back by it, but it wasn’t damaged 
enough to do anything, it still worked.  
Tubing catching - frequency 
I It still worked.  
P Yeah it was fine.  
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I That must be a pain though having to be aware of this 
cord sometimes? 
 
P Yeah. It’s got caught it doors, it’s got caught in quite a 
lot of things. 
Tubing catching 
I Yeah, like things like door handles and things like 
that? 
 
P Yeah, it’s been caught in a door handle and it just 
ripped right off. 
Tubing catching and cannula 
coming out 
I That sounds painful?  
P It’s so fast though it’s less painful than taking it out 
normally. It just feels, it just feels like a sudden 
release. I did have it off cause when it came off in 
school I had it off for the whole day, it felt really good 
to have, cause it does feel weird to have, to, and 
especially when you’re like walking and you feel it 
rubbing, it does feel weird. It felt so good not to have 
something heavy on me, not to have, and I was glad 
I’d gone through the injections cause it felt so good 
just to be able to walk knowing there’s nothing there. 
Pump not working – release 
from the heaviness of pump 
 
Pump rubbing 
Pump heavy 
Pump permanently with 
you/attached to you 
I So that’s one of the disadvantages of the pump?  
P Yeah  
I It is a little bit heavy, it’s always there and you can’t 
take it off. It’s permanently with you. 
 
P Mmmm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 | P a g e  
 
Appendix 2.7 – Research Proposal  
 
Title:  An interpretative phenomenological analysis on the effects of continuous 
subcutaneous insulin infusion (CSII) therapy on children and adolescent’s quality of life 
 
Abstract 
Background: Continuous subcutaneous insulin infusion (CSII) therapy has been endorsed by 
the National Institute for Clinical Excellence (NICE, 2008), who state that it has the ability to 
improve quality of life as it allows for an increase in lifestyle flexibility and greater 
independence as well as improving patients’ blood glucose control. However, investigations 
regarding the impact of CSII therapy on quality of life has utilised a variety of methods, 
which have resulted in conflicting results (Barnard et al., 2007). 
Aims: The primary aim of this study is to investigate the impact CSII therapy can have on 
paediatric and adolescent’s quality of life, using interpretative phenomenological analysis. 
Methods:  6-12 participants aged between 8 and 14 years with type 1 diabetes, and utilising 
CSII therapy, will be recruited from the Glasgow Royal Hospital for Sick Children diabetes’ 
clinic. Each participant will complete an in-depth interview, exploring their beliefs and 
attitudes towards CSII therapy, and its impact on their quality of life.  
Applications: The findings of this study can be used to help to direct resources to help young 
patients with type 1 diabetes achieve optimal quality of life. 
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1.0 Introduction 
   
1.1 Background 
The World Health Organisation (2006) classify diabetes as “a condition primarily defined by 
the level of hyperglycaemia giving rise to risk of microvascular damage”, and it is reportedly 
associated with complications such as myocardial infarction, cardiac revascularisation, 
stroke, kidney disease, diabetic eye disease, and foot complications (Scottish Diabetes 
Survey, 2009). There is also evidence that indicates that diabetic patients often have a 
reduced life expectancy and diminished quality of life (Scottish Intercollegiate Guidelines 
Network (SIGN), 2010). There are two forms of diabetes, type 1 and type 2. Type 1 diabetes 
is characterised by deficient insulin production, whose causation is unknown and therefore 
unpreventable, whereas as the more common form, type 2 diabetes, results from the body’s 
ineffective use of insulin and is usually accredited to excess body weight and physical 
inactivity (WHO), 2006). 
 
The rising incidence of type 1 diabetes in Scottish children over the last 30 years has resulted 
in Scotland achieving the status of the “most common metabolic disease in the young” 
(Scottish Diabetes Survey, 2009; SIGN, 2010). Currently, 6.4% of people with type 1 
diabetes in Scotland are aged between 5-14years old (Scottish Diabetes Survey, 2009), 
putting Scotland in the lead position for the highest diabetes incidence in the world (SIGN, 
2010). Consequently, the SIGN Guidelines (2010) have produced recommendations 
regarding the treatment of type 1 diabetes. They recommend the use of continuous 
subcutaneous insulin infusion (CSII) for those with very low insulin requirements (such as 
infants and very young children), for whom even small doses of insulin may result in 
hypoglycaemia, and also state that it should be considered in all patients who experience 
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recurring episodes of severe hypoglycaemia. CSII therapy has also been endorsed by the 
National Institute for Clinical Excellence (NICE, 2008), who state that it has the ability to 
improve quality of life as it allows for an increase in lifestyle flexibility and greater 
independence as well as improving patients’ blood glucose control.  
 
 
1.2 Late Childhood and Type 1 Diabetes 
Within paediatric/adolescent populations, late childhood to early adolescence is known to be 
a complex transitional period. Erikson (1956) stated that there were a multitude of tasks 
which adolescent’s must undertake in order to progress through the lifecycle; for example, 
establishing an identity, developing peer and romantic relationships and establishing greater 
independence and autonomy. Research has indicated that these developmental stages can be 
adversely affected by the presence of a chronic disease such as type 1 diabetes (Suris et al., 
2004).  
 
Barnard, Lloyd and Skinner (2007) conducted a systematic review of studies addressing the 
impact that CSII could have on a patient's quality of life with regard to adult and 
paediatric/adolescent populations, and concluded  that there were conflicting findings; these 
they considered were possibly due to variations in study quality and quality of life 
assessments used. They included three uncontrolled observational studies in a 
paediatric/adolescent population in which all three reported significant improvements in 
quality of life (McMahon et al., 2005; Mednick et al., 2004; Litton et al., 2002). However, 
one non-randomised controlled study and three randomised controlled trials reported no 
significant difference in quality of life between patients on CSII or Multiple Daily Injections 
(MDI) (Boland et al., 1999; Wilson et al., 2005; Weintrob et al., 2003; Fox et al., 2005). 
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Despite this, the most robust study cited, conducted by Hoogma and colleagues (2005), 
suggested that CSII does have a significant positive impact on quality of life. Nevertheless, 
Barnard and colleagues (2007) were forced to conclude that there was no robust evidence to 
support or oppose the view that quality of life benefits are associated with CSII.  
 
1.3 Quality of Life 
Despite the multitude of studies investigating quality of life, and wide recognition that 
chronic health conditions which require self-management places greater demands on the 
individual (Speight, 2009), there is currently no agreed definition. For the purpose of this 
study, Gill and Feinsteins (1995) definition of quality of life has been adopted. They state that 
quality of life is an “individual’s appraisal of the degree to which their lives contain features 
that they find satisfying or meaningful”. Further, they state that generally, individuals define 
quality of life in terms of fulfilment or purpose, personal control, interpersonal relationships, 
participation in pleasant activities, personal and intellectual growth and material possessions” 
(Barnard et al., 2007; Gill and Feinstein, 1995). 
 
2.0 Aims 
To date, investigations regarding the impact of CSII therapy on quality of life has utilised a 
variety of methods, which have resulted in conflicting results. Additionally, many studies 
have not focused exclusively on children and adolescents, or utilised qualitative 
methodology. Therefore, this study aims to explore the impact an insulin pump can have on 
the quality of life of children and adolescents’ age 8 – 14 years old, using qualitative analysis. 
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3.0 Plan of Investigation 
 
3.1 Participants 
Participants will be recruited from the Glasgow Royal Hospital for Sick Children’s diabetes 
clinic. They must have a diagnosis of type 1 diabetes as specified by their consultant and 
which is in line with the World Health Organisation (2006) criteria. They must have been on 
an insulin pump for a minimum of 1 year, up to 2 years, in order for sufficient time to pass to 
have an effect participant’s quality of life. Further, they must be aged 8 – 14 years old. 
  
3.2 Inclusion Criteria 
1) Have a diagnosis of type 1 diabetes as specified by their consultant and which is in 
line with the World Health Organisation (2006) criteria  
2) Participants must have been on CSII therapy for a minimum of 1 year, up to 2 years, 
and prior to starting this treatment must have been on Multiple Daily Injections for a 
minimum of six months 
3) Age 8 – 14 years old 
4) Attend the diabetes clinic the Glasgow Royal Hospital for Sick Children  
5) No known learning disability 
6) No additional medical illness (mental or physical) 
7) English must be their first language 
8) Written consent by both participant and their parents/guardians must be obtained 
 
3.3 Recruitment Procedure 
A member of the diabetes team will approach patients who match the inclusion criteria (and 
their parent/guardian) either in the diabetes clinic or by telephone, inviting them to participate 
103 | P a g e  
 
in the research study. If patients express interest, both the participant and their 
parent/guardian will be provided with an information sheet, and an indication of how they 
wish to be contacted will be passed onto the principle researcher. An appointment will 
subsequently be arranged with interested patients, either at the time of their next diabetes 
clinic appointment or at another more suitable time. Participating patients and their 
parent/guardian will be asked to provide written informed consent. The opportunity to ask 
further questions will be available prior to the acquisition of consent. Participants will be 
recruited on a first come basis and recruitment will continue until the required number of 
participants has been met, or saturation of themes has been achieved. 
 
3.4 Interview 
A semi-structured interview, lasting approximately 30 – 45 minutes, will be conducted on an 
individual basis. This interview will be recorded using a digital voice recorder. The 
interviews will be structured using an interview schedule developed through discussion with 
the principal researcher and supervisors, and using ‘The Common Sense Model of Self-
regulation of Health and Illness’ as a theoretical framework (Leventhal et al., 1984). For the 
purpose of the interview, the term ‘insulin pump therapy’ will be used instead of CSII as this 
is the term the participants are more familiar with. The interview schedule will be piloted 
with a subset of the sample (n = 3) in order to practice interview technique and to assess the 
appropriateness of the topic areas. Subsequently, the interview topics will be revised 
according to the emerging themes in the pilot interviews. Further, to ensure reliability of the 
analysis, a second experienced researcher will independently analyse a sample of the 
transcripts. 
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3.5 Design 
The study will use a retrospective qualitative design with in-depth interviews. Concerns 
regarding the reliability of retrospective memory were noted, with particular emphasis on 
recall bias (Moss & Goldstein, 1979).  There is however, accumulating research evidence that 
suggests that retrospective reporting is usually accurate and stable, especially when an 
individual is recalling a salient experience (e.g. Blane, 1996; Norris et al., 1992) and 
changing method of medication delivery would be a highly salient event. However, if it 
proved difficult to elicit and compare participant’s beliefs and expectations regarding 
changing to CSII, a greater exploration of how type 1 diabetes can affect participant’s quality 
of life would be carried out. 
 
3.6 Justification of Sample Size 
Between 6 – 12 participants will be recruited, dependent on respondent rates. This is in 
accordance with Guest and colleagues (2006) who suggest that is the number of participants 
required to reach data saturation. Further, Smith and Eatough (2006) indicate that this will 
allow the researcher to explore the participants’ narratives in depth and allow a greater 
understanding of the participants’ experiences. Data collection will be deemed completed 
when either when saturation of themes is reached or 12 participants have been interviewed. 
 
3.7 Settings and Equipment 
Interviews will be conducted by the principle researcher, within a private room in the 
Glasgow Royal Hospital for Sick Children. The interview will be conducted on an individual 
basis, lasting approximately 30 – 45 minutes and will be audio recorded using a digital voice 
recorder. They will be transcribed verbatim by the principle researcher, and all identifiable 
information will be removed to preserve anonymity. The recordings will be stored on an 
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encrypted laptop and when transcription is completed and checked, each recording will be 
destroyed. 
 
3.8 Data Analysis 
The use of the qualitative methodology Interpretative Phenomenological Analysis (IPA)  
will be employed to analyse this data. This dynamic process allows the researcher to gain a 
deeper understanding of the participants’ individual experiences by attempting to gain an 
‘insider’s perspective’, whilst taking into consideration the principle researchers own 
thoughts and theoretical concepts of such experiences (Smith and Osborn, 2008). 
Interpretation is both empathetic and critical, exploring the area of concern, with no attempt 
to test a predetermined hypothesis. 
 
The analysis involves verbatim transcription of the interviews and requires the principal 
researcher to transcribe, code and then identify themes within the transcripts by following a 
six phase process (Smith and Eatough, 2006). Themes will be identified as recurrent when 
referred to by at least half of the participants. A sample of transcripts will be independently 
analysed by a second researcher and reliability checked by comparison of the identified 
themes. 
 
4.0 Health and Safety Issues 
 
4.1 Researcher Safety Issues  
The interviews will be conducted on an individual basis, and thus the safety of both the 
researcher and participant will be ensured by conducting all interviews within normal 
working hours and will comply with standard safety procedures. When participants are being 
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interviewed, hospital staff will be nearby and available if required, and a panic alarm will be 
situated in the room. No domiciliary visits will be conducted. 
 
4.2 Participant Safety Issues 
Written consent will be obtained from both from the participant and their parent/guardian, 
and the opportunity to opt-out (with no repercussions) at any time will be made clear. 
Confidentiality will be explained to participants at the outset and an opportunity will be given 
for the participant or their parent/guardian to ask questions. If any participant discloses 
information which indicates that they or others are at risk, those involved will act 
professionally and appropriately, respecting the limits of confidentiality. If psychological 
difficulties are apparent, this will be discussed with the participant and their parent/guardian, 
and they will have the option of requesting a referral to the dedicated psychology service 
attached to the Diabetes clinic. 
 
5.0 Ethical issues  
Ethical approval will be sought from Greater Glasgow NHS Trust Ethics Committee as well 
as the local Research and Development department at the Royal Hospital for Sick Children. 
 
Participants and their parent/guardian will be asked to provide written informed consent to 
participate in this study. They will have the opportunity to opt-out (with no repercussions) at 
any time from the study, and will receive written information sheets explaining that their 
responses are confidential and will not influence their future treatment in any way.  
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Data will be handled in accordance with The Data Protection Act (1998), the Freedom of 
Information Act (2000) and the NHS Confidentiality Code of Practise Guidelines (2003). All 
identifying information will be removed to preserve anonymity. Audio recordings will be 
stored on an encrypted laptop and when transcription has been completed, each recording will 
be destroyed. 
 
6.0 Financial Issues 
Equipment costs will amount to one digital voice recorder and transcribing kit (to be 
borrowed from the University of Glasgow), and photocopying costs. Travel expenses for the 
primary researcher to and from appointments at the Glasgow Royal Hospital for Sick 
Children will also be required. 
 
7.0 Timetable 
 
May 2011:   Submit proposal to University 
June/July 2011:  Proposal assessed 
Aug/Sept 2011:  Apply for ethical approval 
October 2011:  Begin recruitment 
Feb/March 2012:  Analysis 
April-June 2012:  Write up research 
July 2012:   Submit research to University 
September 2012:  Viva 
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8.0 Practical Applications 
The Diabetes team at the Glasgow Royal Hospital for Sick Children are providing a greater 
number of insulin pumps for children and adolescents’ and thus are developing their service 
in accordance with this. Hence, the team is supportive of this research as they may be able to 
utilise the findings of this study to direct resources to help young patients with type 1 diabetes 
achieve optimal quality of life. 
 
9.0 References 
 
Barnard, K. D., Lloyd, C. E., & Skinner, T. C. (2007). Systematic literature review: Quality 
of life associated with insulin pump use in type 1 diabetes. Diabetic Medicine, 24(6), 607-17. 
 
Blane, D.B. (1996). Collecting retrospective data: development of a reliable method and a 
pilot 
study of its use. Social Science and Medicine, 42, 751-757. 
 
Boland, E. A., Grey, M., Oesterle, A., Frederickson, L., & Tamborlane, W. V. 
(1999).Continuous subcutaneous insulin infusion: a new way to lower risk of severe 
hypoglycaemia, improve metabolic control, and enhance coping in adolescents with type 1 
diabetes. Diabetes Care, 22, 1779 – 1784. 
 
Braun, V. & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research 
in Psychology, 3, 77-101. 
 
Data Protection Act 1998. (1998). London: Stationery Office. 
109 | P a g e  
 
Fox, L. A., Buckloh, L. M., Smith, S. D., Wysocki, T. & Mauras, N. (2005). A randomised 
controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes 
Care, 28, 1277 – 1281. 
 
Gill, T. M. & Feinstein, A. R. (1995). A critical appraisal of the quality of quality-of-life 
measurements. The Journal of American Medical Association, 272, 619 – 626. 
 
Guest, G., Bunce, A & Johnson, L (2006). How Many Interviews Are Enough? An 
Experiment with Data Saturation and Variability. Field Methods, 18, 59-82. 
 
Hoogma, R.P.L.M., Hammond, P. J., Gomis, R., Kerr, D., Bruttomesso, D., Bouter, K. P. et 
al. On behalf of the 5 Nations Study Group (2005). Comparison of the effects of 
subcutaneous insulin infusion (CSII) and NPH-based multiple daily injections (MDI) on 
glycaemic control, and quality of life: results of the 5-nations trial. Diabetic Medicine, 23, 
141 – 147. 
 
Leventhal, H., Nerenz, D.R. & Steele, D.J. (1984). Illness Representations and Coping with 
Health Threats. In: Broadbent, E., Petrie, K.J. & Weinman, J. (2006). The Brief Illness 
Perception Questionnaire. Journal of Psychosomatic Research, 60, 631-637. 
 
Litton, J., Rice, A., Friedman, N., Oden, J., Lee, M. M., Freemark, M. (2002). Insulin pump 
therapy in toddlers and preschool children with type 1 diabetes mellitus. Journal of 
Pediatrics, 141, 490 – 495. 
 
110 | P a g e  
 
McMahon, S. K., Airey, F. L., Marangou, D. A., McElwee, K. J., Carne, C. L., Clarey, A. J. 
Et al. (2005). Insulin pump therapy in children and adolescents: Improvements in key 
parameters of diabetes management including quality of life. Diabetic Appraisal, 22, 92 – 96. 
 
Mednick, L., Cogen, F.R., Streisand, R. (2004). Satisfaction and quality of life in children 
with type 1 diabetes and their parents following transition to insulin pump therapy. 
Children’s Health Care, 33, 169 – 183. 
 
Moss, L. & Goldstein, H. (1979). The recall method in social surveys. In: Blane, D.B. (1996). 
 
Collecting retrospective data: development of a reliable method and a pilot study of it’s use. 
Social Science and Medicine, 42, 751-757. 
 
National Institute for Clinical Excellence Technology Appraisal Guidance 151 (2008). 
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Review of 
technology appraisal guidance 57. Available at: http://guidance.nice.org.uk/TA151 [Accessed 
December 2010]. 
 
National Health Service (2003). Confidentiality Code of Practise Guidelines. London: 
Stationery Office.   
 
NHS Scotland (2009). Scottish Diabetes Survey. Scottish Diabetes Survey Monitoring 
Group,. Available at: 
http://www.diabetesinscotland.org.uk/Publications/Scottish%20Diabetes%20Survey%202009
.pdf [Accessed December 2010]. 
 
111 | P a g e  
 
Norris, F.H. & Kaniasty, K. (1992). Reliability of delayed self-reports in disaster research. 
Journal of traumatic stress, 5, 575-588. 
 
Scottish Intercollegiate Guidelines (2010). Management of Diabetes. (SIGN publication 116) 
[online] Edinburgh (published 2010) Available at: http://www.sign.ac.uk/pdf/sign116.pdf 
[Accessed December 2010] 
Smith, J. A. and Eatough, V. (2006). Interpretative Phenomenological Analysis. In: 
Breakwell, G. M., Hammond, S., Fife-Schaw, C & Smith, J. A. Research Methods in 
Psychology. Sage Publications Ltd. 
 
Suris, J. C., Michaud, P. A., & Viner, R. (2004). The adolescent with a chronic condition. 
Part I: Developmental issues. Archive of Diseases in Childhood, 89 (10), 938–942. 
 
The World Health Organisation (2006). Definition and diagnosis of diabetes mellitus and 
intermediate hyperglycemia. Report of a WHO/IDF Consultation. Available at: 
http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes
_new.pdf [Accessed December 2010]. 
 
The Freedom of Information Act (2000). London: Stationery Office.   
 
Wagner J. A, Abbott G, & Lett S. (2004). Health and quality of life outcomes. BioMed 
Central, 2, 54. 
 
Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G. Et al. (2003). 
Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimes 
112 | P a g e  
 
in children with type 1 diabetes: a randomised open crossover trial. Pediatrics, 112, 559 – 
564. 
 
Wilson, D. M., Buckingham, B. A., Kunselman, E. L. & Sullivan, M. M. (2005). A two-
center randomised controlled feasibility trial of insulin pump therapy in young children with 
diabetes. Diabetes Care, 28, 15-19. 
 
 
 
